Convulsions, not elsewhere classified

R18_CONVU_NOT_ELSEW_CLASSIFIED

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — R56 Cause of death: ICD-10 — R56 2 out of 7 registries used, show all original rules.	13028
4. Check minimum number of events None	13028
5. Include endpoints None	13028
6. Filter based on genotype QC (FinnGen only)	12523

Control definitions (FinnGen only)

Control exclude: R18_GENERAL_SYMPTOMS_SIGNS

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: R[5-6]
Name in latin: Convulsiones non alibi classificatae

NAME	R18_CONVU_NOT_ELSEW_CLASSIFIED
CONTROL_EXCLUDE	R18_GENERAL_SYMPTOMS_SIGNS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	R56
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	R56
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Convulsions, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	12523	5809	6714
Unadjusted period prevalence (%)	2.60	2.06	3.08
Median age at first event (years)	47.81	41.69	53.10

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
12955: Matched controls
127891

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

P16

ICPC

Acute alcohol abuse

7.5

322.5

473

644

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

126.1

320.4

164

N05BA06

ATC

lorazepam; systemic, sublingual

4.5

319.5

817

1879

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

12.6

319.4

316

253

N03AX16

ATC

[U] pregabalin

2.4

319.2

2650

12276

Z3231

NOMESCO Finland

Registered nurse

2.2

313.0

3661

19567

X59

ICD-10 Finland

Exposure to unspecified factor

2.4

311.8

2762

13153

N03AX14

ATC

levetiracetam; systemic

46.1

307.7

2441

641

N05BA02

ATC

chlordiazepoxide; systemic

7.1

307.7

533

768

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

17.5

307.7

293

169

F10.09

ICD-10 Finland

Alcohol intoxication UNS

9.0

307.7

661

759

TPH04

NOMESCO Finland

Cathetrisation of vein

2.5

307.7

2866

13235

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

5.9

307.7

621

1088

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.5

307.7

1449

4398

N05AH04

ATC

quetiapine; oral

3.7

307.7

3426

11279

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

66.5

307.7

212

F10.25

ICD-10 Finland

Alcohol dependence continuous use

13.8

307.7

690

518

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

44.2

307.7

1517

383

R41.0

ICD-10 Finland

Disorientation, unspecified

7.6

307.7

629

858

XA400

NOMESCO Finland

EEG

30.7

307.7

322

106

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

5.1

307.7

3102

7455

N03AX09

ATC

lamotrigine; oral

8.0

307.7

1441

1979

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.7

307.7

1422

4107

N03AE01

ATC

clonazepam; systemic

5.6

307.7

1103

2077

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

39.6

307.7

4440

1661

N03AX23

ATC

brivaracetam; systemic

50.6

307.7

192

Z2445

NOMESCO Finland

Psychologist

4.4

307.7

907

2130

G40.9

ICD-10 Finland

Epilepsy, unspecified

51.2

307.7

3074

772

R50.9

ICD-10 Finland

Fever, unspecified

6.7

307.7

2002

3375

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.3

307.7

1330

4248

G40

ICD-10 Finland

Epilepsy

36.7

307.7

634

179

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

307.7

5609

31045

F10.24

ICD-10 Finland

Alcohol depence active use

13.9

307.7

557

412

G40.89

ICD-10 Finland

Other epilepsy

48.3

307.7

320

G41.9

ICD-10 Finland

Status epilepticus, unspecified

38.7

307.7

381

100

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

14.4

307.7

357

252

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

11.8

307.7

936

837

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.0

307.7

1445

3882

AA1AD

NOMESCO Finland

CT of head and brain

7.4

307.7

6002

13293

A28

ICPC

Limited function/disability NOS

2.9

307.7

2014

7569

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

67.5

307.7

797

124

N05AX08

ATC

risperidone; systemic

4.3

307.7

1589

4059

N05BA09

ATC

clobazam; oral

39.0

307.7

443

116

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.9

307.7

2427

9425

AA1BD

NOMESCO Finland

Extensive CT of head and brain

9.7

307.7

581

616

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

9.1

307.7

532

599

WX892

NOMESCO Finland

Monitored bed care

4.1

307.7

1339

3509

S06.0

ICD-10 Finland

Concussion

3.6

307.7

1978

6164

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

9.3

307.7

1038

1186

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

4.5

307.7

1503

3660

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.6

307.7

4376

20814

F32.9

ICD-10 Finland

Depressive episode, unspecified

3.4

307.7

2398

7976

N05BA04

ATC

oxazepam; oral

2.7

307.7

3716

16383

G40.10

ICD-10 Finland

Simple partial seizures

25.3

307.7

383

154

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.6

307.7

2003

4075

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

14.8

307.7

336

229

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

3.6

307.7

1914

5799

F10.20

ICD-10 Finland

Alcohol dependence currently independent

11.7

307.7

714

634

N05CD08

ATC

midazolam; nasal, systemic

9.2

307.7

624

699

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.6

307.7

3343

15164

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

7.3

307.7

689

980

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.6

307.7

1181

3423

N07

ICPC

Convulsion/seizure

74.1

307.7

236

N05CF01

ATC

zopiclone; oral

2.4

307.7

4067

20376

R56.0

ICD-10 Finland

Febrile convulsions

3760.3

307.7

740

P15

ICPC

Chronic alcohol abuse

7.9

307.7

929

1235

N06AB04

ATC

citalopram; systemic

2.8

307.7

2955

12182

W19

ICD-10 Finland

Unspecified fall

3.1

307.7

1575

5537

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

8.7

307.7

2367

3210

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

17.1

307.7

429

256

R56.8

ICD-10 Finland

Other and unspecified convulsions

68521.8

307.7

12428

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

10.9

307.7

535

502

N03AB02

ATC

phenytoin; systemic

16.9

307.7

447

270

N88

ICPC

Epilepsy

58.3

307.7

478

N03AF02

ATC

oxcarbazepine; oral

36.5

307.7

2452

813

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.1

307.7

902

1847

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

57.9

307.7

1948

390

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

4.3

307.7

1553

3970

183

Kela drug reimbursment

Lamotrigin and topiramate

47.8

307.7

719

157

N05AA02

ATC

levomepromazine; systemic

6.5

307.7

951

1545

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

9.2

307.7

409

452

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

20.9

307.7

254

122

XF400

NOMESCO Finland

ECG with 12 standard connections

3.7

307.7

2649

8245

N05BA01

ATC

diazepam; systemic, rectal

6.0

307.7

3088

6310

N06AX11

ATC

mirtazapine; oral

2.6

307.7

4683

23131

T36

ICD-10 Finland

Poisoning by systemic antibiotics

8.8

307.7

1394

1720

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

3.4

307.7

1321

4118

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

54.2

307.7

2002

430

N03AX18

ATC

lacosamide; systemic

60.5

307.7

652

112

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

30.8

307.7

608

204

N05AH03

ATC

olanzapine; systemic

5.3

307.7

1495

3063

XA800

NOMESCO Finland

Neuropsychological investigation

6.1

307.7

1027

1780

R40.2

ICD-10 Finland

Coma, unspecified

19.2

307.7

290

152

N06AX16

ATC

venlafaxine; oral

2.9

307.7

2088

7823

N05CD07

ATC

temazepam; oral

3.3

307.7

1656

5437

F05.9

ICD-10 Finland

Delirium, unspecified

8.6

307.7

446

531

R55

ICD-10 Finland

Syncope and collapse

31.3

307.7

2506

972

TAB00

NOMESCO Finland

Lumbar puncture

5.0

307.7

759

1563

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

3.7

307.7

2750

8778

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

10.7

307.7

655

633

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

13.7

307.7

413

307

R51.80

ICD-10 Finland

Headache

6.7

307.7

2143

3681

N03AG01

ATC

valproic acid; systemic, rectal

15.9

307.7

2809

2190

N03AF01

ATC

carbamazepine; oral, rectal

9.7

307.7

1458

1646

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

53.9

307.7

299

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

65.0

307.7

751

121

N07BB01

ATC

disulfiram; oral

6.6

307.7

1219

1967

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

4.4

307.7

1186

2836

Z2446

NOMESCO Finland

Social worker

4.2

307.7

1318

3332

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

9.0

307.7

1086

1290

R53

ICD-10 Finland

Malaise and fatigue

3.4

307.7

3179

11142

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

45.0

307.7

277

N05AF03

ATC

chlorprothixene; systemic

6.3

307.7

574

928

N03AX11

ATC

topiramate; oral

7.9

307.7

513

663

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

14.2

307.7

433

311

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

46.3

307.7

431

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

6.8

307.7

2053

3452

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

33.9

307.7

403

121

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

47.7

307.4

181

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

14.2

306.1

282

200

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

8.0

305.4

422

536

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

301.8

3286

17032

A06AD11

ATC

lactulose; oral

2.7

301.8

1820

7219

N05AX12

ATC

aripiprazole; systemic

4.2

300.2

850

2112

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.4

299.0

440

601

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.4

297.2

773

1800

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

11.1

296.9

318

288

R11

ICD-10 Finland

Nausea and vomiting

3.2

294.5

1264

4149

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.0

293.0

1457

5208

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.7

289.1

1793

7204

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.8

287.9

946

2614

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

35.8

283.5

179

N05AH02

ATC

clozapine; systemic

6.3

283.2

486

782

S01.0

ICD-10 Finland

Open wound of scalp

3.2

281.6

1241

4134

N05AD01

ATC

haloperidol; systemic

5.2

280.9

594

1164

WX730

NOMESCO Finland

Conventional respirator

7.8

277.5

390

505

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

25.3

272.2

192

N06AB06

ATC

sertraline; oral

2.7

271.0

1701

6863

ZXD05

NOMESCO Finland

Urgent procedure

2.0

269.0

3851

21996

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.9

266.6

1381

5038

N03AX12

ATC

[U] gabapentin; oral

2.5

263.9

1841

7814

N06AB10

ATC

escitalopram; oral

2.2

263.7

2858

14683

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

17.1

261.3

218

128

R60.0

ICD-10 Finland

Localized oedema

3.1

259.7

1160

3889

R4110

NOMESCO Finland

Physiotherapy

2.1

259.4

3347

18365

P18

ICPC

Medication abuse

15.3

257.0

227

149

C03CA01

ATC

furosemide; systemic

2.1

254.0

3020

16052

G72.8

ICD-10 Finland

Other specified myopathies

8.7

254.0

326

378

G41.0

ICD-10 Finland

Grand mal status epilepticus

59.5

253.6

143

Z3226

NOMESCO Finland

Physiotherapist

2.3

252.9

2323

11136

TKC20

NOMESCO Finland

Catheterisation of bladder

3.4

252.0

988

3059

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

94.0

250.1

132

N03AX22

ATC

perampanel; oral

54.5

247.8

142

N06AB03

ATC

fluoxetine; oral

2.6

247.6

1629

6710

N02AA05

ATC

oxycodone; systemic

2.5

247.2

1822

7919

Z72.1

ICD-10 Finland

Alcohol use

7.8

247.0

347

449

B18.2

ICD-10 Finland

Chronic viral hepatitis C

8.5

246.8

322

381

C07AA05

ATC

propranolol; systemic

2.2

244.5

2606

13254

R42

ICD-10 Finland

Dizziness and giddiness

2.2

243.7

2493

12472

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

9.1

241.2

298

329

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.9

240.9

748

1982

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.8

240.6

763

2052

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

238.7

1034

3399

SPAT1265

SPAT

Breathalyser

9.5

236.2

283

300

N05BE01

ATC

buspirone; oral

5.0

235.7

524

1071

L28

ICPC

Limited function/disability (L)

2.4

234.7

1881

8479

E87.6

ICD-10 Finland

Hypokalaemia

5.1

232.9

505

1010

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

15.5

232.7

204

132

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

231.3

1529

6301

P19

ICPC

Drug abuse

8.3

228.7

304

368

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

29.8

227.9

152

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

2.5

227.3

1648

7092

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

225.7

4331

26997

N06AX21

ATC

duloxetine; oral

2.7

223.8

1339

5249

L01AX03

ATC

temozolomide; systemic

12.3

223.4

224

183

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

13.1

222.8

215

165

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.2

220.7

333

467

Z72.2

ICD-10 Finland

Drug use

12.9

220.3

214

166

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

3.1

219.9

963

3182

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

217.7

2448

12653

R4120

NOMESCO Finland

Occupational therapy

3.2

215.7

934

3065

N05BA12

ATC

alprazolam; oral

2.7

212.6

1250

4851

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

7.9

210.9

293

374

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

4.0

208.8

610

1545

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

15.7

208.4

181

115

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

4.2

206.6

571

1388

K92.0

ICD-10 Finland

Haematemesis

5.3

206.5

423

804

K86.00

ICD-10 Finland

Acute pancreatitis caused by alcohol

7.3

205.0

306

424

F60.9

ICD-10 Finland

Personality disorder, unspecified

7.5

204.2

295

394

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

7.1

202.8

309

438

T90.5

ICD-10 Finland

Sequelae of intracranial injury

8.2

202.5

273

336

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

202.0

4038

25309

N02AX02

ATC

tramadol; systemic, rectal

1.8

201.9

4671

30590

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

69.1

201.7

111

ZY010

NOMESCO Finland

Hospital outpatient

3.2

201.4

865

2822

A02BC02

ATC

pantoprazole; systemic

1.7

199.8

7434

55664

F10.03

ICD-10 Finland

Alcohol-related acute intoxication with delirium

19.8

199.5

155

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

20.0

198.8

154

N05AB03

ATC

perphenazine; systemic, rectal

4.1

198.7

564

1398

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

17.8

198.3

162

R52.2

ICD-10 Finland

Other chronic pain

5.8

197.9

369

643

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

8.2

196.7

265

326

XF600

NOMESCO Finland

Bloodpressure measurement

3.1

194.3

868

2897

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.1

193.5

413

814

WX882

NOMESCO Finland

High dependency care

4.4

193.3

502

1163

N04AA02

ATC

biperiden; systemic

5.8

192.3

359

626

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

6.5

191.3

315

485

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

22.9

191.3

140

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

7.4

190.9

282

386

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

16.8

190.6

160

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

26.7

189.3

131

F20.9

ICD-10 Finland

Schizophrenia, unspecified

5.0

189.3

419

852

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

17.9

189.0

154

N03AX15

ATC

zonisamide; oral

22.9

188.7

138

N05CF02

ATC

zolpidem; oral

2.1

188.3

2006

10104

K70.1

ICD-10 Finland

Alcoholic hepatitis

12.4

186.9

186

150

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

6.6

186.9

304

462

SPAT1254

SPAT

Administration of medicine

2.1

183.9

1975

9971

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.2

183.8

1674

7915

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

5.1

182.1

396

793

R62.0

ICD-10 Finland

Delayed milestone

35.8

182.1

115

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

3.7

179.7

597

1653

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.7

178.6

254

333

E86

ICD-10 Finland

Volume depletion

5.7

178.3

338

598

WX408

NOMESCO Finland

General anesthesy, balanced

1.9

177.9

3019

17858

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.0

177.8

819

2779

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

4.4

176.6

454

1043

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

22.1

176.6

131

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

25.2

175.7

124

A41.9

ICD-10 Finland

Sepsis, unspecified

4.3

175.7

466

1097

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

7.3

175.1

261

361

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.0

175.0

827

2847

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

3.5

173.5

613

1768

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

8.0

172.8

236

295

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.3

172.2

356

682

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.7

170.2

569

1582

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

3.0

169.9

779

2635

P29

ICPC

Psychological sympt/compl other

2.5

169.9

1130

4641

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

169.3

843

2986

R25.2

ICD-10 Finland

Cramp and spasm

4.8

168.3

390

824

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

14.8

168.2

151

102

R52.1

ICD-10 Finland

Chronic intractable pain

30.7

168.1

111

N06AX03

ATC

mianserin; oral

3.5

167.9

611

1796

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

2.6

167.0

1074

4340

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

165.5

2193

11916

N05AB01

ATC

dixyrazine; systemic

7.3

163.5

243

335

N06AA09

ATC

amitriptyline; systemic

2.7

163.3

955

3680

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.0

163.3

758

2581

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.8

162.9

858

3132

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

10.7

162.1

178

167

ZXE20

NOMESCO Finland

More than three and less than five hours

2.2

161.0

1560

7540

D64.9

ICD-10 Finland

Anaemia, unspecified

2.5

160.7

1147

4865

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

3.6

160.0

544

1529

ZY000

NOMESCO Finland

Hospital inpatient

5.9

159.2

291

497

Z2221

NOMESCO Finland

Medical doctor

1.8

158.4

3162

19554

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

157.5

1304

5904

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

13.0

157.1

152

117

C07AB07

ATC

bisoprolol; oral

1.7

155.7

4775

33191

N05AN01

ATC

lithium; oral

4.4

155.5

401

923

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

3.6

155.4

541

1544

V03AA01, ,

ATC

5.5

152.6

298

542

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

5.4

152.5

309

581

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.0

152.1

234

335

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

151.0

1220

5461

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.1

150.9

1592

7941

K90

ICPC

Stroke/cerebrovascular accident

4.4

150.1

381

866

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

149.0

2494

14584

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

9.3

148.8

180

193

P99

ICPC

Psychological disorders other

3.7

148.6

488

1339

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.6

147.8

500

1400

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

5.5

147.7

292

537

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

147.6

2994

18544

A04

ICPC

Weakness/tiredness general

2.0

147.3

1771

9266

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

146.8

1156

5116

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.0

146.3

698

2411

N06AA12

ATC

doxepin; systemic

3.2

146.3

603

1914

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

145.9

1394

6685

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

3.6

145.7

509

1456

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

16.0

145.2

125

S06.3

ICD-10 Finland

Focal brain injury

6.1

144.0

254

419

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

12.7

143.8

141

111

7803A

ICD-9 Finland

General symptoms, Convulsions

6.1

142.6

250

410

F61.0

ICD-10 Finland

Mixed personality disorders

5.2

142.3

298

577

SPAT1227

SPAT

Substance abuse rehabilitation

9.1

142.2

175

192

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

5.9

142.0

258

438

A46

ICD-10 Finland

Erysipelas

2.1

141.6

1547

7808

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

6.7

141.5

227

340

K86.08

ICD-10 Finland

Alcohol-induced chronic pancreatitis

12.9

141.2

137

106

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.7

140.2

451

1220

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.7

140.1

812

3110

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

19.7

140.0

109

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.6

139.0

476

1343

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

8.6

138.5

179

209

N02BF02

ATC

pregabalin; oral

3.0

137.8

647

2214

ZXE00

NOMESCO Finland

One hour or less

1.6

137.4

4335

30112

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

137.3

719

2612

R52.9

ICD-10 Finland

Pain, unspecified

2.5

136.5

958

4022

G81.9

ICD-10 Finland

Hemiplegia, unspecified

8.3

136.3

180

216

SPAT1234

SPAT

Support of social functional capacity

3.1

136.0

594

1950

IGY02

NOMESCO Finland

Psychiatric monitoring contact

3.5

135.5

487

1418

N02BE01

ATC

paracetamol; systemic, rectal

1.8

135.1

10431

89712

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

134.6

1007

4351

X58

ICD-10 Finland

Exposure to other specified factors

1.9

133.7

1811

9854

N06AB05

ATC

paroxetine; oral

2.7

133.6

745

2796

SPAT1240

SPAT

Therapeutic discussion

2.1

133.3

1467

7415

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

133.1

1048

4631

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

132.7

2041

11576

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

131.7

693

2523

EBA00

NOMESCO Finland

Extraction of tooth

1.6

131.4

4544

32188

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

15.2

131.3

116

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

11.6

131.2

136

117

G41.2

ICD-10 Finland

Complex partial status epilepticus

37.0

130.9

T74.1

ICD-10 Finland

Physical abuse

4.2

130.5

351

834

ZXD35

NOMESCO Finland

Usual procedure

3.6

129.9

451

1284

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

10.8

129.0

140

129

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

15.1

128.7

114

P72

ICPC

Schizophrenia

4.4

128.7

330

756

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.7

128.2

758

2929

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

127.9

1074

4875

SPAT1247

SPAT

Outpatient detoxication and monitoring

10.3

127.9

144

140

A10AB05

ATC

insulin aspart; parenteral

2.4

127.8

950

4090

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.4

127.1

949

4093

N06AA06

ATC

trimipramine; systemic

4.4

126.7

329

761

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

29.8

126.0

SPAT1216

SPAT

Assessment of functional ability

2.0

124.9

1519

7951

A86

ICD-10 Finland

Unspecified viral encephalitis

12.8

124.3

121

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.7

124.3

404

1100

SPAT1229

SPAT

Assessment of need for aid

2.6

123.6

750

2935

WX872

NOMESCO Finland

Intensive care

2.8

122.8

633

2278

S06.2

ICD-10 Finland

Diffuse brain injury

6.3

121.5

208

333

RS222, ,

NOMESCO Finland

6.2

121.1

208

334

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

22.1

119.9

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

3.9

119.8

355

906

M03BX01

ATC

baclofen; systemic

5.1

119.3

254

499

N05AA01

ATC

chlorpromazine; systemic, rectal

5.7

118.7

223

391

S00.0

ICD-10 Finland

Superficial injury of scalp

4.2

118.4

325

784

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

5.5

118.4

232

423

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

118.4

687

2628

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.8

118.3

217

372

A01

ICPC

Pain general/multiple sites

2.3

118.2

949

4221

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

5.7

118.2

222

389

S22.3

ICD-10 Finland

Fracture of rib

2.4

118.2

829

3473

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

12.1

118.0

119

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

117.8

1099

5201

S18

ICPC

Laceration/cut

1.6

117.8

4868

35693

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

3.8

116.5

371

996

R33

ICD-10 Finland

Retention of urine

2.4

116.4

865

3720

K59.09

ICD-10 Finland

Constipation, unspecified

2.6

115.9

686

2650

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

115.5

3991

28062

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.4

115.3

433

1296

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

4.4

115.1

292

663

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.7

114.9

378

1038

J01MA12

ATC

levofloxacin; systemic

1.9

114.6

1788

10148

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

6659

43993

2.02

322.16

7.6

5.3

0.04

e9/l

1.05

5717

37807

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

9097

67257

2.13

321.40

9.5

5.9

82.30

77.02

u/l

16.76

8645

62883

(3001604) Monocytes [#/volume] in Blood

6641

43890

2.01

320.29

7.6

5.3

0.61

0.58

e9/l

9.34

5708

37750

(3002582) Erythrocytes [#/volume] in Urine

4328

24520

2.11

319.32

4.0

2.8

83.27

86.19

e6/l

0.04

3434

18176

(40760892) CBC W Ordered Manual Differential panel - Blood

6323

41124

2.01

318.59

8.0

5.7

—

(3013115) Eosinophils [#/volume] in Blood

6828

45698

2.00

316.21

8.4

5.4

0.18

0.20

e9/l

8.32

5924

39883

(3026008) Bacteria identified in Urine by Culture

4094

22832

2.13

313.77

3.5

2.5

—

(3019198) Lymphocytes [#/volume] in Blood

6818

45787

1.99

310.60

7.6

5.2

1.95

2.00

e9/l

0.85

5967

40372

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2898

13214

2.50

307.65

2.8

1.7

1.76

1.37

78.33

2539

11807

(3016502) Oxygen saturation in Arterial blood

1981

7174

3.04

307.65

9.0

7.8

95.52

95.86

1.22

1921

6881

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2873

10516

3.18

307.65

2.1

1.6

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

7471

51100

2.05

307.65

13.0

7.4

4.25

4.07

e9/l

7.96

6481

44036

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

331

268

12.49

307.65

1.2

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

6576

35793

2.65

307.65

13.4

12.8

1.19

1.24

inr

5.15

2060

10290

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

7044

41605

2.47

307.65

7.6

4.9

11.64

12.06

umol/l

1.06

6663

39117

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2091

6906

3.37

307.65

2.0

1.5

—

(3002032) Base excess in Venous blood by calculation

2158

6534

3.71

307.65

5.2

3.5

1.56

1.70

mmol/l

0.84

1827

5358

(3024354) Oxygen [Partial pressure] in Venous blood

1837

5421

3.73

307.65

4.6

2.9

4.79

4.70

kpa

0.93

1760

5228

(3026782) Osmolality of Urine

3248

15544

2.42

307.65

3.2

2.5

524.47

569.09

mosm/kgh2o

21.03

2840

13174

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2175

6561

3.73

307.65

5.2

3.4

5.86

5.81

kpa

1.41

2090

6359

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1236

3715

3.53

307.65

9.5

9.9

24.07

24.16

mmol/l

0.38

1194

3587

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5028

28750

2.19

307.65

4.2

2.9

36.49

32.90

u/l

3.13

4749

27208

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

907

1470

6.47

307.65

1.7

1.3

492.96

505.22

mg/l

0.25

868

1401

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3219

11163

3.46

307.65

2.5

2.0

29.40

29.92

4.23

3130

10820

(3020779) Urea [Moles/volume] in Serum or Plasma

1765

6499

2.95

307.65

8.0

6.5

8.07

9.29

mmol/l

10.50

1679

6180

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4523

24575

2.26

307.65

3.4

2.2

56.81

65.03

u/l

1.65

4212

22554

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2937

14041

2.38

307.65

4.4

3.1

268.54

727.09

ng/l

5.50

2202

10374

(3012544) pH of Venous blood

2204

6805

3.65

307.65

5.2

3.5

7.38

7.37

0.32

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1378

3608

4.10

307.65

5.4

3.8

23.81

23.87

mmol/l

0.23

1337

3547

(3013826) Glucose [Moles/volume] in Serum or Plasma

8461

49565

2.98

307.65

7.3

3.9

6.64

6.68

mmol/l

0.71

8083

45253

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

496

443

11.45

307.65

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2097

7009

3.33

307.65

2.1

1.5

—

(3023368) Bacteria identified in Blood by Culture

4429

18880

3.00

307.65

5.5

3.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

838

1268

6.91

307.65

1.6

1.2

3.85

3.73

mmol/l

1.88

778

1196

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7178

34594

3.35

307.65

8.1

5.2

1.20

1.21

mmol/l

54.97

6852

31318

(3003396) Base excess in Arterial blood by calculation

2334

7979

3.30

307.65

8.3

7.4

0.95

0.84

mmol/l

0.48

1845

6257

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

803

1302

6.42

307.65

1.8

1.4

716.23

4105.55

e6/l

0.63

647

1039

(3028707) Methadone [Presence] in Urine by Screen method

1021

2099

5.13

307.65

5.1

2.4

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

5995

33764

2.40

307.65

5.9

4.3

34.71

36.31

g/l

69.56

5596

31241

(3020191) Ethanol [Moles/volume] in Serum or Plasma

635

641

10.23

307.65

2.1

1.2

1.24

1.49

promille

2.28

497

503

(3023183) Ammonium ion [Moles/volume] in Plasma

1055

1218

9.22

307.65

3.1

2.5

34.31

33.47

umol/l

0.44

972

1110

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2320

7972

3.28

307.65

8.3

7.4

5.09

5.10

kpa

0.16

2225

7581

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

370

170

22.09

307.65

3.0

2.9

29.36

27.59

umol/l

1.10

261

135

(3027801) Oxygen [Partial pressure] in Arterial blood

2320

7970

3.28

307.65

8.3

7.4

12.94

12.78

kpa

0.56

2221

7576

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

6542

21379

5.08

307.65

3.4

1.9

278.68

238.71

u/l

1.21

6338

19919

(3003181) Sodium [Moles/volume] in Urine

604

895

6.94

307.65

1.6

1.5

66.90

67.13

mmol/l

0.03

475

707

(3009466) Valproate [Moles/volume] in Serum or Plasma

1363

912

16.37

307.65

4.9

5.1

367.94

374.92

umol/l

0.56

1219

768

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

788

195

42.41

307.65

2.6

2.4

53.47

50.78

umol/l

0.66

703

174

(3044290) Cell count panel - Cerebral spinal fluid

772

1224

6.56

307.65

1.8

1.3

—

(3000991) Gas panel - Venous blood

2006

6213

3.59

307.65

9.1

8.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2042

6026

3.78

307.65

7.8

7.3

1.51

1.36

mmol/l

5.88

1987

5855

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1843

6650

3.02

307.65

9.2

8.2

122.20

123.43

g/l

1.58

1806

6442

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1410

2067

7.43

307.65

2.5

2.4

356.59

840.90

ug/l

2.25

1343

1910

(3012095) Magnesium [Moles/volume] in Serum or Plasma

3312

11232

3.57

307.65

4.4

3.1

0.79

0.82

mmol/l

32.18

3136

10492

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

325

263

12.49

307.65

1.2

1.1

—

(3018418) pH of Serum or Plasma

4902

21692

2.98

307.65

4.6

3.4

7.40

0.05

993

3983

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1789

4750

4.15

307.65

8.1

7.4

24.46

24.65

mmol/l

1.29

1777

4719

(3033658) Prothrombin time (PT) actual/Normal

4165

20869

2.43

307.65

5.8

3.3

88.27

90.26

5.77

4070

20366

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7652

38259

3.38

307.65

8.8

5.7

1.20

1.21

mmol/l

57.44

6693

32329

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

802

1302

6.42

307.65

1.7

1.4

31.08

17.02

e6/l

0.39

606

979

(3003458) Phosphate [Moles/volume] in Serum or Plasma

2555

9599

3.03

307.65

6.8

5.4

1.05

mmol/l

0.08

2410

8907

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5178

28585

2.31

307.65

4.6

2.8

66.04

84.23

ng/l

0.21

3714

17550

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1750

6460

2.94

307.65

2.3

2.2

382.79

381.01

nmol/l

0.10

1607

5912

(3036180) Methadone [Presence] in Urine

475

484

10.02

307.65

3.5

1.8

—

(3030467) Casts [#/volume] in Urine by Automated count

4010

22366

2.12

305.77

3.8

2.7

0.41

0.39

e6/l

0.15

3169

16384

(3019309) Folate [Moles/volume] in Red Blood Cells

2766

13284

2.34

305.54

1.9

1.6

1184.23

1143.45

nmol/l

1.41

2154

9941

(3022096) Basophils/100 leukocytes in Blood

6138

39930

1.98

304.49

7.8

5.4

0.63

0.68

9.28

5758

37044

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

186

38.00

299.31

2.9

3.8

42.26

37.14

umol/l

0.93

166

(3006504) Eosinophils/100 leukocytes in Blood

6286

41460

1.96

297.13

7.8

5.4

2.64

2.91

18.01

5902

38595

(3019069) Monocytes/100 leukocytes in Blood

6315

41735

1.96

296.54

8.1

5.6

8.79

8.47

11.96

5932

38916

(36304419) Bacteria [Presence] in Urine

3902

22032

2.07

284.10

3.8

2.6

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1384

4888

3.01

283.92

5.1

3.5

5.18

5.11

kpa

2.36

1328

4621

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1191

3860

3.25

282.98

1.6

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

3630

20006

2.10

281.66

2.4

2.1

2.93

2.84

mg/l

1.38

3077

17008

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1298

4442

3.09

281.28

10.2

9.5

0.68

0.67

0.57

1290

4420

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1294

4448

3.08

278.15

10.2

9.4

1.51

1.33

6.37

1286

4425

(3002030) Lymphocytes/100 leukocytes in Blood

6449

43570

1.92

276.85

7.8

5.4

27.49

29.12

25.23

6082

40817

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1704

6822

2.69

275.95

2.7

2.3

0.21

0.22

g/l

6.65

1532

6373

(3023410) Appearance of Cerebral spinal fluid

420

597

7.14

275.25

2.0

1.5

—

(3009343) pH of Capillary blood

1360

4837

2.98

275.19

5.1

3.5

7.42

7.41

0.37

191

490

(3000850) Epithelial cells [#/volume] in Urine

3122

16428

2.15

272.06

3.1

2.3

6.30

5.28

e6/l

3.64

2845

14526

(3018095) Leukocytes [#/volume] in Urine

4812

29683

1.96

269.68

4.6

3.1

74.42

78.24

e6/l

0.15

3604

19798

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1323

4703

2.98

267.66

5.1

3.5

1.52

1.50

mmol/l

0.07

964

3342

(3016018) Differential panel - Cerebral spinal fluid

434

659

6.69

267.43

1.8

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

351

422

8.41

265.66

1.4

1.2

2.08

1.94

mmol/l

1.14

317

399

(3018010) Neutrophils/100 leukocytes in Blood

6332

42913

1.89

265.23

7.6

5.2

57.22

56.32

7.02

5965

40170

(3015377) Calcium [Moles/volume] in Serum or Plasma

4319

25809

1.98

264.48

3.8

2.9

2.34

2.36

mmol/l

17.13

3835

22686

(3031040) Bacteria [#/volume] in Urine by Automated count

8007

58642

1.91

262.29

5.5

3.5

1803.59

1461.10

e6/l

0.18

118

820

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1111

3612

3.23

261.99

1.8

1.4

—

(3011288) Drugs identified in Urine by Screen method

1152

3833

3.16

261.29

6.9

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1269

4496

2.98

257.91

4.7

1.8

—

(3028271) Lactate [Moles/volume] in Capillary blood

521

981

5.42

257.41

2.4

1.7

2.18

1.74

mmol/l

6.59

507

954

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

344

423

8.22

255.56

1.7

1.5

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3162

17132

2.09

252.60

1.7

1.4

18.54

20.27

nmol/l

9.58

2812

14669

(3010421) pH of Blood

708

1747

4.17

251.71

4.6

3.6

7.41

7.42

3.31

651

1597

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

283

278

10.25

249.70

1.7

1.6

—

(3012501) Base excess in Blood by calculation

648

1505

4.42

249.37

4.6

3.7

2.26

2.40

mmol/l

0.56

445

978

(3013290) Carbon dioxide [Partial pressure] in Blood

648

1506

4.42

249.16

4.6

3.7

5.04

4.98

kpa

1.28

637

1477

(3027315) Oxygen [Partial pressure] in Blood

649

1512

4.41

248.76

4.6

3.7

8.67

8.87

kpa

1.86

638

1482

(40758558) Short blood count panel - Blood

3700

21320

2.00

248.65

9.3

5.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1692

7129

2.54

245.21

3.2

2.1

33.35

58.61

u/l

1.39

1449

6090

(3004119) Hemoglobin [Mass/volume] in Venous blood

1167

4083

3.00

242.01

4.4

3.0

129.54

132.02

g/l

2.94

1139

3987

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

5050

32639

1.86

237.60

2.1

1.8

92.85

96.03

pmol/l

4.98

2856

17185

(3028626) Oxygen [Partial pressure] in Capillary blood

728

2004

3.74

221.69

5.9

3.8

8.84

8.71

kpa

0.88

707

1953

(3016879) Cocaine [Presence] in Urine

1381

5535

2.64

220.65

4.8

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

4266

26791

1.85

214.77

2.9

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

382

639

6.05

213.74

22.3

18.8

5661.69

1367.88

nmol/l

0.80

377

617

(3000764) Benzodiazepines [Presence] in Urine

1434

5959

2.55

212.32

4.7

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1203

4595

2.75

211.03

1.8

1.5

—

(1616796) Gas panel - Central venous blood

589

1448

4.16

209.98

4.1

3.4

—

(3028300) Cannabinoids [Presence] in Urine

1440

6032

2.53

209.51

4.8

1.8

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

370

617

6.06

207.66

15.1

13.2

2197.08

825.23

nmol/l

0.47

364

597

(3022948) Iron [Moles/volume] in Serum or Plasma

2300

11806

2.12

207.25

2.8

2.2

12.39

13.89

umol/l

16.91

2114

11023

(3019060) Gas panel - Arterial blood

1173

4465

2.75

207.00

6.1

4.7

—

(3027008) Opiates [Presence] in Urine

1432

6024

2.51

206.33

4.4

1.7

—

(40767503) Oxygen content in Capillary blood by calculation

564

1367

4.21

204.87

3.1

2.3

16.71

16.89

0.40

256

700

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

395

716

5.59

203.13

1.1

—

16.01

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2138

10750

2.15

202.86

2.8

2.2

2.27

2.39

g/l

15.09

1946

9929

(3022806) Fractional oxyhemoglobin in Capillary blood

416

796

5.30

201.58

2.3

1.6

89.60

89.93

0.47

402

783

(3021589) Normoblasts [#/volume] in Blood

5817

40691

1.75

199.19

12.4

7.7

0.00

e9/l

0.35

4725

33071

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1842

8801

2.24

198.19

3.2

2.4

9.12

8.36

umol/l

0.53

1548

7641

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2007

9971

2.17

195.78

2.9

2.3

22.38

23.56

2.66

1707

8481

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1126

4319

2.72

195.39

9.0

6.7

24.47

24.39

mmol/l

0.24

1080

4086

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

254

300

8.51

194.86

3.2

1.9

146.52

175.73

umol/l

0.42

129

150

(3027945) Reticulocytes/100 erythrocytes in Blood

1702

7946

2.28

193.30

3.1

2.4

1.86

1.69

7.92

1507

7007

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1068

4024

2.77

191.73

10.4

9.8

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

606

1637

3.78

189.27

4.3

3.0

24.37

24.42

mmol/l

0.08

594

1594

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2377

12750

2.03

188.43

3.4

2.5

3.45

2.45

e6/l

3.51

1291

6679

(3027944) Amphetamines [Presence] in Urine

1380

5957

2.44

187.18

4.4

1.7

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1650

7734

2.27

185.12

3.7

3.8

241.24

240.96

u/l

0.02

1549

7295

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2458

13504

1.98

181.36

3.2

2.4

1.19

1.04

e6/l

1.05

1364

7414

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

518

1294

4.07

180.46

1.5

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

518

1295

4.07

180.27

1.5

1.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2894

16833

1.90

180.00

2.2

1.6

1.40

1.23

mg/l

1.36

2200

12468

(3042936) Bacteria identified in Isolate by Culture

2084

10852

2.07

178.30

2.4

1.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

1898

9549

2.13

177.91

2.0

1.6

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2383

13030

1.99

177.87

3.1

2.7

2.44

mmol/l

0.36

2038

11291

(3019550) Sodium [Moles/volume] in Serum or Plasma

11308

97601

2.13

176.77

26.0

11.3

138.68

139.73

mmol/l

241.41

11130

94542

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

158

11.58

176.13

1.3

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

887

3175

2.89

174.92

4.4

3.0

25.16

25.02

mmol/l

0.58

855

3072

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

3316

20317

1.82

173.87

2.8

2.0

—

(3024928) Oxygen saturation in Venous blood

536

1446

3.77

167.52

3.9

3.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

8293

65594

1.69

167.28

5.0

2.7

66.85

42.54

u/l

51.84

7912

61502

(3023103) Potassium [Moles/volume] in Serum or Plasma

11300

97962

2.09

167.24

25.6

11.4

3.95

3.96

mmol/l

6.38

11100

94654

(3016038) Potassium [Moles/volume] in Urine

254

363

7.03

165.37

1.4

1.6

28.98

36.49

mmol/l

4.56

208

320

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

564

1597

3.60

164.08

1.3

1.2

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

813

2885

2.90

162.63

5.0

3.4

51.44

48.35

2.74

805

2844

(3037467) Urinalysis macro (dipstick) panel - Urine

7978

62764

1.66

161.24

5.1

3.5

—

(3008295) Osmolality of Serum or Plasma

339

659

5.19

161.22

1.5

1.6

276.10

283.86

mosm/kgh2o

4.78

265

523

(3020891) Body temperature

766

2662

2.96

159.08

6.4

4.4

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

660

2138

3.16

154.84

2.2

1.8

2.55

2.26

ug/l

0.25

572

1873

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1288

5847

2.30

154.46

2.5

2.0

6.60

8.48

ug/l

2.90

1112

5140

(3036489) Thrombin time

811

2961

2.82

153.71

2.9

2.1

21.51

21.40

0.20

741

2557

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

328

669

4.94

147.54

1.1

1.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

4879

34485

1.64

146.54

2.6

2.1

72.09

74.82

nmol/l

8.06

4428

31251

(3018405) Lactate [Moles/volume] in Arterial blood

676

2316

2.99

143.77

5.0

4.0

1.53

1.42

mmol/l

1.33

662

2284

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1561

7886

2.08

142.59

4.7

2.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

152

137

11.07

142.18

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

11208

98171

1.94

141.44

22.3

9.6

23.92

23.83

mg/l

0.11

9560

73632

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

147

128

11.46

140.67

1.2

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1231

5696

2.25

140.48

2.8

2.4

72.27

68.84

e9/l

2.03

887

4207

(3042517) Benzodiazepines panel - Urine

129

13.67

137.67

3.5

1.9

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

3083

19585

1.73

137.51

3.0

2.7

1492.18

1309.32

ng/l

1.23

2611

16422

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

149

138

10.77

136.83

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

148

136

10.86

136.64

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

5672

42125

1.59

135.37

3.0

2.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

566

1814

3.18

134.97

1.7

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

143

129

11.05

133.67

1.1

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1196

5580

2.23

133.49

2.6

2.4

10.63

10.68

g/l

0.11

1066

5062

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1245

5927

2.19

132.13

4.7

3.2

1.21

1.23

mmol/l

17.97

1141

5076

(3021901) Oxygen saturation in Capillary blood

422

1140

3.74

131.41

3.8

2.8

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

770

2979

2.65

129.97

1.9

1.7

1.47

1.45

g/l

0.20

656

2541

(3022313) Gas panel - Capillary blood

891

3727

2.46

127.74

5.7

3.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

174

223

7.79

124.71

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1099

5104

2.23

123.68

1.9

2.3

65.57

67.11

g/l

7.43

1002

4614

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

270

559

4.85

119.28

1.4

1.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

815

3380

2.47

118.84

5.9

3.7

24.47

24.64

mmol/l

0.96

786

3152

(3043409) Potassium [Moles/volume] in Arterial blood

569

1985

2.91

116.83

5.5

4.2

3.82

3.91

mmol/l

3.66

563

1975

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

263

556

4.75

113.32

1.9

1.4

—

(3013707) Erythrocyte sedimentation rate by Westergren method

8087

66475

1.53

113.24

4.2

3.4

12.73

10.25

mm/h

36.94

7501

61231

(3001122) Ferritin [Mass/volume] in Serum or Plasma

5338

40280

1.52

111.30

3.3

2.6

133.59

111.18

ug/l

3.96

4888

37507

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

703

2862

2.51

106.43

6.6

4.8

1.93

1.69

3.99

665

2655

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

8563

71704

1.53

106.22

4.3

3.5

14.45

14.67

pmol/l

12.88

7833

64724

(3008402) Methanol [Moles/volume] in Serum or Plasma

14.60

104.16

1.5

1.1

—

mmol/l

—

(3009508) Creatinine [Moles/volume] in Urine

3899

27803

1.55

103.61

4.6

3.2

7.48

8.30

mmol/l

19.47

3363

23743

(3007930) Methemoglobin/Hemoglobin.total in Blood

688

2821

2.49

102.52

6.7

4.8

0.88

0.92

1.42

652

2616

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

421

1334

3.19

102.12

1.7

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

206

386

5.34

102.06

1.9

1.6

2682983.41

1661115.84

iu/ml

0.42

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

412

1301

3.20

100.51

1.8

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

586

2247

2.65

100.31

3.6

2.8

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

182

309

5.88

100.20

1.4

1.3

53.05

70.17

1.29

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

567

2147

2.68

99.50

3.6

3.5

0.33

0.34

u/ml

0.24

326

1190

(3017143) Hepatitis C virus Ab [Presence] in Serum

1999

12214

1.73

98.63

1.8

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

15.16

98.41

1.2

1.1

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

612

2424

2.57

98.04

3.7

2.6

3.41

3.57

g/l

1.66

594

2306

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

122

9.46

97.31

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

19.85

95.32

1.1

—

(3015736) pH of Urine

4770

35967

1.49

95.30

3.9

2.8

6.10

5.90

2.92

212

3172

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

180

322

5.58

93.81

2.3

140.28

154.78

nmol/l

0.78

154

277

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

394

1273

3.12

92.45

6.0

5.3

492.29

699.80

iu/ml

0.39

176

(3013512) EKG study

3254

22788

1.55

91.61

4.2

3.3

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

285

753

3.80

91.57

5.9

6.4

10.89

10.90

mg/l

0.01

254

692

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1017

5145

2.03

90.65

4.6

3.8

90.05

86.25

ng/l

0.53

897

4488

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

13.90

90.61

1.2

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

264

667

3.97

90.34

4.3

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

313

894

3.52

89.60

4.1

2.8

1558.28

595.47

u/ml

0.38

(3035350) Ketones [Presence] in Urine by Test strip

5644

44371

1.45

89.11

4.2

3.0

0.00

estimate

0.04

1255

8458

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

250

620

4.04

87.77

1.2

1.1

35.31

43.84

mg/l

2.87

205

516

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

308

884

3.50

87.52

1.8

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

888

4349

2.09

86.31

1.7

1.8

1.28

1.32

g/l

0.30

812

3955

(3035637) Corticotropin [Mass/volume] in Plasma

308

893

3.46

86.16

1.6

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

220

505

4.36

85.57

1.4

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

5662

44815

1.44

84.69

4.2

3.0

0.01

0.00

estimate

0.64

1165

7831

(3007164) IgA [Mass/volume] in Serum or Plasma

2663

18128

1.57

83.94

1.5

1.4

2.46

2.30

g/l

3.23

1549

10974

(3024666) Lithium [Moles/volume] in Serum or Plasma

227

542

4.19

83.87

14.3

10.9

0.61

mmol/l

0.16

208

493

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

610

2599

2.38

83.31

3.4

2.5

89.95

91.93

1.11

593

2497

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

146

241

6.04

82.76

1.1

85.24

327.77

ng/l

1.13

(3000570) Elastase.pancreatic [Mass/mass] in Stool

490

1892

2.62

82.57

1.4

250.45

285.49

ug/g

2.66

287

1081

(3021601) Nitrite [Presence] in Urine by Test strip

5597

44356

1.43

82.33

5.6

4.1

0.00

estimate

1.60

1220

8104

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

103

9.46

82.25

1.1

—

(3047181) Lactate [Moles/volume] in Blood

566

2352

2.44

81.70

7.6

5.5

1.45

1.26

mmol/l

2.44

501

2056

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

516

2071

2.52

80.25

1.8

1.6

—

(3004588) Protein electrophoresis panel - Serum or Plasma

829

4066

2.08

80.11

1.6

2.1

—

(3044889) 12 lead EKG panel

7441

62236

1.42

79.97

4.0

3.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

9943

87823

1.51

79.85

5.3

4.1

1.88

2.09

mu/l

2.66

9268

80548

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2474

16729

1.57

79.78

1.7

1.6

11495831.98

34427474.08

pmol/l

2.32

2053

13928

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

235

602

3.91

78.90

1.1

234.89

269.91

mg/l

1.92

205

537

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

560

2353

2.41

78.85

4.0

2.5

190.34

180.74

1.68

541

2235

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

268

754

3.56

78.51

1.9

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

601

2626

2.32

77.42

1.9

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

315

993

3.18

77.03

1.6

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

228

585

3.90

76.39

1.1

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2859

20134

1.52

76.09

3.8

3.0

—

(3019225) pH of Specimen

1273

7331

1.79

75.86

4.5

3.4

—

(40768797) Stomach Pathology biopsy report

1658

10309

1.67

74.97

1.3

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

13.62

74.64

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

201

479

4.19

74.48

1.7

1.6

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

16.02

73.33

1.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3123

22570

1.48

72.71

2.2

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

383

1394

2.76

72.46

1.5

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

118

7.91

68.60

1.2

1.1

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

478

1994

2.42

68.32

2.0

1.6

0.22

0.23

g/l

0.85

441

1896

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2957

21393

1.47

67.67

1.4

1.3

1.95

1.97

u/ml

0.03

704

5704

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1032

5778

1.83

67.18

3.1

2.7

212.94

185.10

ng/l

1.07

927

5195

(3017181) Myelocytes/100 leukocytes in Blood

1129

6527

1.78

65.99

4.5

3.8

0.96

0.88

0.43

463

1832

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

486

2076

2.36

65.86

2.0

1.6

1.15

1.16

g/l

0.25

452

1976

(3019150) Specific gravity of Urine by Refractometry

2739

19608

1.48

65.85

4.6

3.2

1.02

kg/l

0.99

374

2983

(3002385) Erythrocyte distribution width [Ratio]

9742

86784

1.44

65.09

27.3

12.1

14.60

14.88

1.40

9617

84955

(1761868) Lipid panel - Serum or Plasma

2828

37023

0.69

65.07

2.9

2.5

—

(3037522) Nuclear Ab [Titer] in Serum

1665

10742

1.61

64.26

1.4

1.3

367.19

538.66

titre

7.14

317

2041

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

282

937

3.01

63.05

1.6

1.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

282

938

3.01

62.93

1.6

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

412

1668

2.49

62.83

2.6

2.1

131.23

132.53

g/l

0.51

331

1184

(21494755) Public health laboratory ask at order entry panel

681

12472

0.51

62.18

1.3

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

201

546

3.68

62.10

3.5

2.8

47425.23

40128.68

ug/l

3.52

201

546

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

228

674

3.38

61.92

1.7

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

606

2907

2.11

61.84

2.0

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

228

675

3.38

61.78

1.7

1.5

—

(3040151) Glucose [Moles/volume] in Capillary blood

263

852

3.09

61.45

8.8

13.5

7.03

7.46

mmol/l

1.03

223

676

(3009445) Proteinase 3 Ab [Units/volume] in Serum

607

2922

2.10

61.37

1.3

1.6

4.79

14.16

u/ml

2.95

102

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

106

7.87

61.05

1.1

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

214

617

3.46

60.44

2.1

1.5

—

(3007463) Buprenorphine [Presence] in Urine

15.61

59.71

4.3

4.8

—

(3039000) Anion gap in Blood

398

1639

2.44

58.50

9.0

6.5

11.37

11.30

mmol/l

0.14

366

1451

(3018572) Chloride [Moles/volume] in Blood

398

1640

2.44

58.42

9.0

6.5

104.02

105.35

mmol/l

4.32

366

1452

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

196

547

3.58

58.19

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1025

6003

1.74

56.96

4.1

3.7

0.72

0.62

0.46

404

1612

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

255

850

3.00

56.72

1.6

1.3

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

935

5367

1.78

55.68

2.3

22.62

21.73

au/ml

0.10

479

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

106

189

5.57

55.54

1.4

1.2

23.69

14.87

0.49

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

225

708

3.18

55.25

1.6

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

3111

23442

1.41

55.17

4.7

3.2

0.00

estimate

0.08

1126

7749

(3021440) Promyelocytes/100 leukocytes in Blood

1052

6284

1.71

54.36

4.6

3.9

0.12

0.10

0.33

393

1597

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

863

4883

1.80

53.91

1.2

45.95

53.24

au/ml

0.34

268

(3024891) Influenza virus A+B Ag [Presence] in Specimen

489

2289

2.15

53.11

1.3

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1242

7802

1.63

52.84

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

9.32

52.42

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.60

51.87

1.1

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2457

17923

1.44

51.80

1.8

1.7

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

9.05

51.28

1.1

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

476

2237

2.14

51.17

1.2

1.3

86.25

126.98

titre

0.57

222

(3016650) Hepatitis A virus Ab [Presence] in Serum

346

1421

2.44

51.17

1.2

1.1

—

(3011648) Oxygen content in Venous blood

192

575

3.33

51.14

5.4

3.0

11.43

11.58

0.16

192

575

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

494

2363

2.11

50.72

7.6

3.6

1.54

1.36

mg/l

4.10

461

2164

(3025159) Blasts/100 leukocytes in Blood

1002

6029

1.69

50.27

4.7

3.9

0.12

0.29

0.89

339

1354

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

461

2158

2.15

50.06

2.5

2.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

9889

89583

1.38

49.88

19.5

9.4

89.61

86.16

ml/min/173m2

35.48

8367

71506

(3000494) Fungus identified in Specimen by Culture

1461

9685

1.55

49.27

1.5

1.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

104

7.06

49.00

7.3

8.1

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

224

760

2.94

48.33

1.7

1.3

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11326

105267

1.49

48.09

13.9

8.0

28.89

27.36

u/l

5.11

11030

101292

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

309

1241

2.49

47.96

1.7

1.5

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

471

2265

2.09

47.68

1.6

2.1

3.83

3.70

g/l

0.87

426

2045

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

471

2268

2.09

47.51

1.6

2.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

471

2273

2.09

47.23

1.6

2.1

7.51

7.26

g/l

2.26

426

2050

(40761511) CBC panel - Blood by Automated count

11234

104321

1.47

47.09

20.1

9.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

449

2142

2.11

46.42

1.7

2.1

3.09

2.84

g/l

4.82

404

1920

(4035726) Immunohistochemistry procedure

1025

6333

1.65

46.33

1.4

1.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

625

10797

0.55

46.02

1.6

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

410

1898

2.17

45.80

1.3

1.5

13.28

12.85

iu/ml

—

(3051593) INR in Capillary blood by Coagulation assay

124

297

4.15

45.77

4.4

11.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

16.09

45.42

1.1

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

382

1740

2.20

44.43

1.4

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

438

2117

2.08

43.74

1.7

2.1

10.19

10.27

g/l

0.11

390

1882

(3023511) Choriogonadotropin [Units/volume] in Urine

479

2398

2.01

43.44

1.6

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

363

1638

2.22

43.22

1.4

1.3

252.09

242.82

u/ml

0.23

209

980

(3048929) Epstein Barr virus Ab [Presence] in Serum

620

3397

1.84

42.89

1.4

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

146

413

3.52

42.57

1.0

282.64

329.10

ng/l

1.18

109

296

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

467

2339

2.01

42.30

1.5

1.6

532.31

255.44

titre

0.52

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

146

415

3.50

42.26

1.0

714.49

758.51

ng/l

0.47

102

288

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

372

1720

2.17

41.69

1.7

2.1

0.01

g/l

0.01

333

1576

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

145

418

3.45

41.09

1.0

36.70

43.62

ng/l

1.30

103

297

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

350

1590

2.21

40.99

1.7

2.1

0.00

g/l

0.78

312

1450

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

144

416

3.44

40.68

1.9

1.3

—

(40761536) Microorganisms panel - Urine sediment

1157

7585

1.56

40.61

5.0

3.1

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

346

1578

2.20

40.14

1.6

1.4

21.89

20.03

u/ml

0.11

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

330

1478

2.24

40.03

1.6

1.4

127.78

109.14

u/ml

0.90

304

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

315

1385

2.28

39.94

1.1

—

(3011412) CD3 cells [#/volume] in Blood

184

624

2.94

39.80

2.8

2.4

1.30

1.26

e9/l

0.24

157

552

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

140

403

3.46

39.77

1.1

1.03

1.04

u/l

0.10

178

(3051651) Icteric interference index of Serum or Plasma

149

447

3.32

39.67

4.1

3.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

126

341

3.67

39.28

2.2

2.6

44.36

67.45

umol/l

0.54

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

102

237

4.27

39.24

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

374

1775

2.11

39.21

1.7

2.0

36.54

38.84

g/l

8.22

329

1548

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

604

3374

1.80

39.19

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

342

1568

2.18

39.16

1.7

2.1

0.00

g/l

-0.00

310

1445

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

344

1581

2.18

39.15

1.6

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

435

2187

2.00

38.99

1.2

1.3

501.25

955.52

titre

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

383

1840

2.09

38.88

2.0

3.1

44.15

46.49

mg/l

0.13

307

1486

(3019977) pH of Arterial blood

126

344

3.64

38.79

3.0

2.8

7.43

7.42

0.17

119

(3034860) Kappa light chains.free [Mass/volume] in Serum

383

1844

2.08

38.66

2.0

3.1

59.43

58.39

mg/l

0.05

307

1488

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

792

4814

1.66

37.97

2.6

2.3

7709.80

6427.06

u/l

0.44

271

1949

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

811

4966

1.65

37.78

3.0

3.4

4.42

4.62

pmol/l

5.66

722

4450

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

396

1949

2.04

37.67

1.7

2.2

0.55

0.90

g/l

1.72

345

1672

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

568

3156

1.81

37.51

2.2

1.8

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

699

4125

1.71

37.44

1.8

1.6

377.74

303.21

mu/l

3.43

617

3744

(3000093) Morphology [Interpretation] in Blood Narrative

189

678

2.78

36.90

1.2

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1472

10353

1.46

36.57

10.3

5.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

213

817

2.60

36.47

2.3

2.7

20.88

20.81

nmol/l

0.02

197

785

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

145

455

3.17

35.92

3.1

2.0

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

304

1378

2.21

35.84

1.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

192

4.50

35.76

3.6

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

192

4.50

35.76

3.6

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

181

646

2.79

35.69

2.7

2.6

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

365

1779

2.06

35.67

2.1

3.1

1.23

2.03

ratio

1.22

131

(36660697) Celiac disease serology panel - Serum

1146

7704

1.51

35.65

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

520

2857

1.83

35.62

1.7

1.8

40.59

38.97

u/l

0.89

471

2549

(3044242) Glucose [Moles/volume] in Arterial blood

112

302

3.68

35.15

2.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

9.90

34.79

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.79

34.72

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

405

7341

0.53

34.67

1.4

—

(3026250) Tacrolimus [Mass/volume] in Blood

111

302

3.65

34.39

37.2

33.4

7.10

7.31

ug/l

0.46

103

277

(3011985) Renin [Units/volume] in Plasma

244

1028

2.37

34.20

1.8

1.5

55.90

73.75

mu/l

0.73

216

929

(3015171) Extractable nuclear Ab [Units/volume] in Serum

502

2777

1.82

33.63

1.2

0.49

0.95

u/ml

1.06

234

(3037121) Protein [Mass/volume] in Urine

494

2721

1.82

33.56

3.3

0.43

0.31

g/l

1.48

281

1213

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

4158

34624

1.27

33.43

4.5

3.0

—

(3008037) Lactate [Moles/volume] in Venous blood

315

1502

2.10

32.67

4.1

2.5

1.79

1.64

mmol/l

1.23

310

1465

(3004809) Band form neutrophils/100 leukocytes in Blood

240

1031

2.32

32.20

3.6

2.9

1.53

1.45

0.11

218

900

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

148

505

2.92

31.76

3.0

2.0

11.67

14.82

4.15

143

494

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

431

2318

1.86

31.62

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

132

424

3.09

31.49

1.2

1.4

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

132

424

3.09

31.49

1.2

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

132

424

3.09

31.49

1.2

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

632

3802

1.67

31.46

1.1

1.29

19.85

u/ml

1.00

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

139

464

2.98

31.03

2.7

2.6

0.22

0.24

e9/l

0.50

110

395

(1175426) CD3 cells/100 lymphocytes in Blood

148

512

2.88

30.98

3.0

2.0

73.74

71.68

0.76

143

495

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

288

1359

2.12

30.72

1.2

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

311

1518

2.05

30.32

1.4

1.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

285

1355

2.10

29.81

2.2

3.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

140

480

2.90

29.81

2.7

2.6

546.17

509.64

e6/l

0.43

111

399

(3008757) Leukocyte morphology finding [Identifier] in Blood

178

695

2.55

29.47

3.6

3.1

—

(3037756) Immunofixation for Serum or Plasma

255

1168

2.18

29.36

1.2

1.6

—

(40761535) Cells panel - Urine sediment

938

6310

1.50

28.89

3.8

2.9

—

(3025941) Bacteria identified in Stool by Culture

759

4877

1.57

28.86

1.3

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

6.14

28.57

1.7

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

657

4111

1.61

27.95

3.4

2.4

0.40

0.25

e6/l

1.27

642

4000

(42529406) Shigella sp [Presence] in Stool by Culture

430

2402

1.79

27.91

1.3

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

427

2388

1.79

27.61

1.3

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

290

3.39

27.51

3.2

2.2

12.81

11.82

0.22

276

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

262

1251

2.09

27.14

1.4

1.2

4.46

4.09

u/ml

0.20

123

567

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

423

2377

1.78

26.92

1.3

1.1

—

(3028433) Virus identified in Specimen by Culture

207

3.83

26.73

1.3

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

7.52

26.70

1.1

1.0

—

(3003434) Protein [Mass/volume] in Pleural fluid

201

869

2.30

26.65

1.5

33.71

33.79

g/l

0.03

181

778

(3024980) IgG subclass 4 [Mass/volume] in Serum

254

1209

2.10

26.54

1.4

1.5

0.61

0.80

g/l

3.14

191

924

(3051611) Lipemic interference index of Serum or Plasma

186

780

2.37

26.45

4.0

2.8

—

(3000060) B lymphocytes [#/volume] in Blood

214

3.75

26.29

3.0

2.2

691.43

609.59

e6/l

0.06

123

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

214

960

2.22

25.99

1.3

1.4

775.85

335.42

pmol/l

0.45

181

835

(3012516) Albumin [Mass/volume] in Urine

2975

24375

1.27

25.97

3.7

3.3

315.27

305.14

mg/l

0.05

2033

15867

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

266

1299

2.04

25.95

1.4

1.2

4.12

3.39

u/ml

0.25

103

441

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

109

352

3.07

25.85

1.4

1.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

278

3.36

25.76

3.1

2.0

29.60

26.15

1.40

268

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

269

3.39

25.67

3.0

2.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

171

704

2.42

25.35

1.5

1.4

66238.42

52854.35

e6/l

0.24

106

412

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

136

503

2.69

25.19

1.3

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

182

774

2.34

25.10

1.5

12142.16

2480.14

e6/l

1.01

132

557

(3020682) Albumin/Creatinine [Ratio] in Urine

3096

25601

1.25

24.78

4.4

3.9

13.66

7.96

mg/mmol

6.14

2039

16607

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

7.27

24.57

1.1

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

105

346

3.01

24.08

1.4

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

205

936

2.18

23.88

1.3

0.59

2.37

nmol/l

0.85

195

901

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

205

936

2.18

23.88

1.3

0.18

0.23

nmol/l

0.37

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

305

3.12

23.45

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

132

500

2.62

23.35

1.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1009

7168

1.42

23.29

3.8

4.0

12.73

25.06

ug/l

1.83

834

5713

(3000012) Reticulocyte production index

200

914

2.18

23.26

2.3

1.9

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

302

3.12

23.19

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

302

3.12

23.19

1.5

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

232

1128

2.05

22.96

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

108

372

2.88

22.92

1.4

1.2

261.23

430.60

u/l

0.75

343

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

187

837

2.22

22.90

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

387

2223

1.74

22.87

2.0

1.7

—

(3017509) Phencyclidine [Presence] in Urine

125

4.44

22.81

3.3

1.6

—

(3035285) Chloride [Moles/volume] in Venous blood

179

789

2.26

22.75

3.1

1.9

104.60

105.58

mmol/l

1.48

179

783

(3041354) Potassium [Moles/volume] in Venous blood

179

789

2.26

22.75

3.1

1.9

4.06

4.08

mmol/l

0.32

179

783

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

320

1744

1.83

22.59

1.9

10.02

10.40

mg/l

0.42

297

1639

(3017569) Oxygen content in Arterial blood

282

3.17

22.52

2.1

2.3

—

(3048689) Calprotectin [Mass/mass] in Stool

1513

11544

1.33

22.40

2.4

2.5

131.09

126.52

ug/g

0.19

1191

9200

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.36

22.09

1.1

1.6

—

(3010375) cycloSPORINE [Mass/volume] in Blood

288

3.10

21.75

28.2

24.5

109.95

124.57

ug/l

0.96

245

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

283

3.12

21.74

2.1

1.3

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

278

3.14

21.73

2.8

2.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

284

3.11

21.61

2.1

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

326

2.95

21.54

2.0

1.3

—

(3012441) Differential panel - Pleural fluid

159

684

2.31

21.43

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

149

623

2.38

21.42

1.2

173.00

198.49

titre

0.15

119

(3032352) Blasts [#/volume] in Cerebral spinal fluid

6.80

21.24

4.4

2.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

533

3391

1.58

21.15

1.5

1.4

8.80

8.00

u/l

0.75

420

2746

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

182

833

2.17

21.13

1.3

—

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

393

2329

1.69

20.76

1.2

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

171

773

2.20

20.49

3.2

1.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

158

695

2.26

20.23

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

18.04

20.20

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

141

592

2.37

20.12

1.1

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

166

753

2.19

19.74

1.5

1.3

6.80

6.66

g/l

0.19

118

520

(3045788) Cell count panel - Pleural fluid

144

618

2.31

19.56

1.4

1.5

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

165

753

2.18

19.34

1.5

1.3

2.75

3.06

g/l

1.09

118

521

(3024139) IgG subclass 3 [Mass/volume] in Serum

165

753

2.18

19.34

1.5

1.3

0.39

0.41

g/l

0.29

115

520

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

104

385

2.68

19.34

1.8

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

125

4.12

19.31

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

267

3.04

19.29

1.4

1.5

12.72

14.48

pmol/l

2.83

214

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

7.00

19.15

4.4

2.7

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

4.95

19.08

1.8

1.2

52.82

64.88

0.59

(3041096) Erythrocytes [Presence] in Urine by Automated

2946

24819

1.22

18.95

4.1

2.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

893

6436

1.40

18.91

3.2

2.3

70.91

70.60

ml/min/173m2

0.07

378

2315

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

154

3.73

18.80

4.1

2.2

1.06

1.94

mmol/l

2.06

119

(4062490) Immunoglobulin typing, IgG

163

749

2.16

18.79

1.5

1.3

—

(40757373) Influenza virus identified in Isolate

132

3.98

18.78

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

7.42

18.76

1.0

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

206

3.32

18.74

1.4

1.3

—

(3020393) Adenovirus Ag [Presence] in Stool

4.58

18.72

1.9

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

331

2.79

18.66

3.7

4.7

1574.27

1303.72

mg/l

0.06

238

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

144

631

2.27

18.65

3.7

3.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

334

5395

0.60

18.58

1.6

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

161

741

2.16

18.50

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

115

458

2.49

18.45

1.6

1.4

12.79

12.16

u/l

0.50

110

448

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

145

644

2.24

18.20

1.1

282.79

283.42

mg/l

0.03

129

580

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

397

2450

1.62

17.94

3.1

3.4

1859.12

1295.86

u/ml

0.19

346

2113

(3005322) IgE [Units/volume] in Serum or Plasma

782

5564

1.41

17.83

1.4

1.2

326.57

280.15

u/ml

0.44

709

5173

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

137

600

2.27

17.79

1.4

1.3

891.06

535.07

u/l

0.42

127

573

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

128

545

2.33

17.75

1.0

1.1

—

(3018133) Calcium [Moles/volume] in Urine

170

3.50

17.69

2.7

3.1

2.71

2.55

mmol/l

0.21

156

(3016244) Insulin [Units/volume] in Serum or Plasma

138

608

2.25

17.67

4.5

3.3

26.09

29.96

mu/l

0.49

122

566

(3014271) Vancomycin [Susceptibility]

283

2.87

17.45

3.5

2.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2608

21858

1.22

17.44

3.0

2.3

3693.60

4634.68

umol/l

0.64

2239

19311

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

252

2.99

17.37

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

252

2.99

17.37

1.4

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

128

551

2.31

17.32

1.0

1.1

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

179

885

2.01

17.05

2.5

2.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

228

1225

1.85

16.96

1.1

115.91

115.02

0.15

206

1105

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

201

1039

1.92

16.84

1.2

1.3

—

(3023419) Bacteria identified in Sputum by Culture

192

982

1.94

16.61

2.5

—

(40768806) Pleura Pathology biopsy report

146

676

2.15

16.57

1.5

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

171

845

2.01

16.33

1.4

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

175

873

1.99

16.28

1.4

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

120

3.88

16.14

7.7

5.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

865

6366

1.37

16.09

1.3

1.2

114.92

153.39

iu/ml

1.54

296

2351

(3025468) Yersinia sp identified in Specimen by Organism specific culture

170

844

2.00

16.03

1.4

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.75

16.02

2.0

2.1

—

(3042631) Mycobacterium sp identified in Specimen

169

838

2.00

15.99

2.2

2.8

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

113

478

2.35

15.96

1.3

18.52

14.86

u/l

0.36

103

446

(3005988) Vibrio sp identified in Specimen by Organism specific culture

170

848

1.99

15.83

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

170

848

1.99

15.83

1.4

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

300

1783

1.68

15.77

2.7

1.8

0.81

0.76

nmol/l

0.62

252

1514

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

179

3.26

15.68

1.4

1.3

124.01

132.94

nmol/l

0.12

134

(3017354) Segmented neutrophils/100 leukocytes in Blood

133

609

2.17

15.56

3.0

59.34

54.95

1.62

113

505

(3036782) Glucose [Moles/volume] in Pleural fluid

133

612

2.16

15.37

1.3

1.4

6.66

6.18

mmol/l

0.99

120

556

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

231

1304

1.76

14.66

4.3

3.1

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

261

2.77

14.62

4.5

3.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

167

852

1.95

14.61

1.4

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

102

430

2.35

14.56

1.2

1.1

1428.92

1438.29

miu/ml

0.03

102

430

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

117

528

2.20

14.23

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.71

14.18

1.6

1.1

21.00

7.25

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

260

2.74

14.17

3.0

2.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

261

1540

1.69

14.15

1.1

88.91

7424.43

iu/ml

0.64

365

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

192

1040

1.83

14.01

1.2

1.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

101

3.92

13.99

1.5

1.3

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

214

2.92

13.88

2.3

1.8

774.25

5022.10

e6/l

0.59

146

(3014148) Varicella zoster virus Ab [Titer] in Serum

231

1326

1.73

13.86

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

379

2.41

13.85

4.0

2.1

148.26

129.86

1.15

351

(3028717) Thiamine [Mass/volume] in Blood

4.59

13.70

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

185

3.05

13.61

2.3

1.7

3378.67

7838.95

e6/l

0.99

(3024869) Neuronal Ab [Presence] in Serum

113

3.68

13.45

1.0

1.1

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.24

13.44

5.9

3.5

2.15

2.59

mg/l

0.44

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

380

2.37

13.31

2.9

2.6

41.86

40.38

0.34

198

(4200892) Spirometry reversibility

797

5968

1.34

13.24

1.5

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

194

2.96

13.15

1.3

1.2

16.38

16.55

umol/l

0.10

170

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

314

1979

1.58

13.11

1.3

1.2

27.19

35.11

u/ml

0.25

113

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

226

1313

1.71

13.01

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

226

1314

1.71

12.98

1.8

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1869

15560

1.22

12.97

2.3

2.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

293

1823

1.60

12.92

1.3

4.49

9.81

u/ml

2.03

278

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

9056

85288

1.16

12.89

5.9

5.0

39.79

39.08

mmol/mol

7.59

8426

79328

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

231

1357

1.69

12.78

3.0

3.4

314.64

903.24

u/ml

0.66

212

1240

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

289

1798

1.60

12.76

1.3

3.78

3.99

u/ml

0.05

178

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

388

2.32

12.72

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

894

1.86

12.70

1.3

1.1

—

(40768446) Kidney Pathology biopsy report

317

2.47

12.63

2.0

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

216

1256

1.71

12.42

1.7

1.9

1531.43

1688.75

titre

—

(3024471) HLA-A [Type]

223

2.75

12.35

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

120

3.46

12.33

1.2

1.5

21.90

25.30

g/l

0.71

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

245

1476

1.65

12.33

1.3

1.2

49.41

40.29

u/ml

0.40

119

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

454

3133

1.45

12.32

1.6

1.7

—

(3044007) Cell count panel - Peritoneal fluid

170

3.03

12.30

1.8

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

155

3.13

12.25

1.2

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

576

4150

1.39

12.25

1.5

1.4

22.56

22.75

iu/l

0.05

449

3513

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

213

2.79

12.25

1.4

1.2

0.28

0.30

g/l

0.97

173

(3003694) ABO and Rh group [Type] in Blood

3349

29484

1.16

12.11

1.5

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

349

2.36

12.00

1.3

1.6

2.32

9.44

nmol/l

0.52

287

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

405

2.25

11.96

1.3

1.5

481.81

485.74

mu/l

0.02

390

(3024932) HLA-DR beta [Type]

222

2.72

11.90

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

117

2231

0.51

11.88

1.5

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

414

2.23

11.78

1.3

1.5

72.76

72.09

0.27

399

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

140

727

1.91

11.73

1.2

1.4

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

723

5434

1.33

11.73

1.4

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

177

990

1.78

11.70

2.3

2.6

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

164

899

1.81

11.60

1.1

96.43

96.38

0.01

155

842

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

130

3.27

11.59

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

171

950

1.79

11.57

2.0

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2016

17081

1.20

11.51

2.4

2.2

—

(3042733) HLA Ab [Presence] in Serum

243

2.61

11.50

4.3

4.8

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

177

2.91

11.48

1.6

1.5

—

(3032057) Clostridioides difficile [Presence] in Stool

121

3.35

11.48

1.9

1.8

—

(40768804) Tissue Pathology biopsy report

3942

35233

1.15

11.46

2.1

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

146

3.12

11.46

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

285

2.47

11.38

5.8

25.20

24.93

mmol/l

0.20

260

(3029634) Reagin Ab [Titer] in Serum by VDRL

242

1486

1.62

11.33

2.1

2.22

7.23

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

316

2.38

11.29

1.1

1.2

—

(3013727) Leukocytes other/100 leukocytes in Blood

224

2.65

11.16

4.8

3.1

46.20

51.55

1.01

210

(3010838) Calcium [Moles/time] in 24 hour Urine

201

1184

1.69

11.07

1.6

1.9

4.83

5.35

mmol/24h

1.26

175

1046

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

165

921

1.78

11.01

1.2

1.3

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

446

2.13

10.97

1.3

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7609

71144

1.14

10.90

3.5

3.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

13.69

10.86

5.3

5.5

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

153

2.98

10.61

1.9

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

191

1126

1.68

10.52

1.1

1.58

1.48

g/l

2.89

171

1016

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1655

13900

1.20

10.33

1.3

1.2

27.54

33.85

iu/ml

1.14

482

4423

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

4.74

10.27

2.3

1.9

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

141

3.02

10.18

1.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

9.41

10.13

4.8

3.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

174

2.79

10.07

2.9

1.8

—

(3035880) pH of Pleural fluid

354

2.21

9.92

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

329

2.26

9.92

1.1

1.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

14.37

9.90

1.1

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.99

9.89

4.8

3.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

121

636

1.89

9.85

2.0

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

407

2.12

9.82

1.7

1.5

14.46

7.26

ug/l

0.73

369

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

150

844

1.76

9.80

1.2

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

233

1472

1.57

9.75

1.2

6.22

3.30

u/ml

0.29

108

(3023420) DNA double strand Ab [Units/volume] in Serum

152

861

1.75

9.71

1.6

1.5

19.73

29.17

iu/ml

0.61

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

397

2.12

9.64

1.2

116.20

80.01

u/l

1.46

337

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

299

2001

1.49

9.60

2.0

1.9

3.74

4.59

iu/l

0.92

101

756

(3045142) Bone marrow Pathology biopsy report

113

586

1.91

9.60

1.4

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

544

7058

0.75

9.56

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

3.72

9.54

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

304

2.28

9.49

1.3

1.5

—

(3003327) Ova and parasites identified in Stool by Light microscopy

426

3052

1.39

9.45

1.8

1.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2660

23390

1.15

9.40

1.7

1.6

1.42

1.37

mmol/l

1.28

2273

19884

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

2.65

1.34

mg/l

0.47

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

2.76

2.53

mg/l

0.05

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

4.05

3.72

mg/l

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

3.42

1.09

mg/l

0.50

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

2.35

1.97

mg/l

0.11

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

5.70

3.74

mg/l

0.40

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

2.48

1.89

mg/l

0.13

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

4.24

9.38

1.7

2.68

0.62

mg/l

0.66

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

127

3.04

9.37

2.5

2.8

22.17

32.15

mg/l

0.39

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

275

2.34

9.37

1.2

1.1

—

(3017732) Neutrophils [#/volume] in Blood

769

6019

1.28

9.26

3.8

2.5

4.41

4.94

e9/l

1.21

622

4977

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.16

9.17

1.7

1.85

1.42

mg/l

0.16

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

178

2.67

9.12

1.2

67.60

69.72

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

3.69

9.11

1.5

1.1

48.04

48.38

mg/l

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

387

2.10

9.08

1.2

31.54

18.97

u/l

1.05

318

(3026389) Candida sp identified in Specimen by Organism specific culture

193

1187

1.61

9.08

1.6

1.3

—

(3022621) pH of Urine by Test strip

715

5560

1.29

9.07

3.4

2.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

202

1260

1.59

8.97

1.4

1.3

19.79

19.87

u/l

0.01

160

1046

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

130

721

1.79

8.96

1.5

1.3

1.20

1.39

nmol/l

1.18

118

644

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

4.94

8.91

1.9

1.3

43.29

30.67

0.47

(3052592) Norovirus Ag [Presence] in Stool

131

2.94

8.90

1.2

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

239

2.40

8.88

2.7

2.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

11738

113648

1.21

8.79

33.2

14.8

39.91

41.09

2.27

11072

106614

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

8.47

8.69

1.1

1.0

—

mmol/l

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

2439

21428

1.15

8.64

1.8

1.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

518

3890

1.33

8.53

2.3

2.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.18

8.47

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

360

2558

1.40

8.43

1.3

—

(3016228) CD19 cells/100 cells in Blood

245

2.34

8.43

2.7

2.0

10.86

9.15

0.36

239

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.89

8.41

1.3

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

152

2.73

8.39

2.0

1.3

10.23

13.18

g/l

1.30

117

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

110

593

1.84

8.35

1.3

1.5

12.88

11.88

umol/l

0.85

563

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

259

2.29

8.31

1.2

1.1

76.48

91.22

2.04

116

(3013336) Amino acids [Identifier] in Serum or Plasma

4.10

8.27

1.6

2.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

6.59

8.25

2.1

2.3

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

150

888

1.68

8.24

1.2

1.3

32.30

50.46

u/ml

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

121

2.94

8.23

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

363

2.07

8.20

1.1

0.34

10.94

nmol/l

2.02

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

177

2.57

8.16

1.1

72.00

80.53

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

249

2.31

8.14

1.4

1.3

74.32

167.65

nmol/24h

1.26

249

(37021550) Renin [Units/volume] in Plasma --upright

138

2.80

8.13

1.2

1.3

56.10

59.61

mu/l

0.06

104

(3044927) Protein electrophoresis panel - Urine

108

584

1.83

8.13

1.2

1.1

—

(3007461) Platelets [#/volume] in Blood

11740

113773

1.20

8.09

32.8

14.8

251.48

251.18

e9/l

0.18

11521

110333

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

250

2.30

8.07

1.3

1.1

—

(3033799) Differential panel - Peritoneal fluid

184

2.53

8.06

1.8

1.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

128

2.86

8.04

1.4

1.9

66.47

20.55

u/l

0.48

117

(3027456) Digoxin [Moles/volume] in Serum or Plasma

180

1123

1.59

8.04

3.2

2.8

0.82

0.81

nmol/l

0.15

131

844

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

374

2700

1.38

7.99

1.6

56.77

3.92

iu/ml

0.70

553

(3012920) Ethanol [Mass/volume] in Serum or Plasma

8.00

7.99

1.2

1.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

103

556

1.84

7.82

1.1

—

51.43

—

(3045414) Leukocytes [Presence] in Urine

488

3684

1.32

7.78

1.9

1.7

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

508

1.87

7.76

1.2

1.1

1.09

1.06

ratio

0.84

179

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

176

2.53

7.75

1.3

3.71

299.74

ug/l

1.33

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1520

12986

1.18

7.72

1.3

1.2

9.05

12.87

u/ml

1.64

514

5171

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

115

2.92

7.70

1.1

1.0

—

(3035941) MCH [Entitic mass]

11744

113883

1.19

7.65

32.6

14.7

30.38

30.19

22.37

11632

112055

(3004451) EKG impression Narrative

295

2.15

7.60

1.3

1.2

—

(3024731) MCV [Entitic volume]

11744

113892

1.19

7.60

32.7

14.7

90.81

90.27

26.86

11632

112060

(3010813) Leukocytes [#/volume] in Blood

11746

113926

1.19

7.51

32.8

14.8

7.08

6.70

e9/l

32.59

11490

110138

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

390

1.98

7.47

1.2

1.1

24.00

25.31

u/ml

—

(3026361) Erythrocytes [#/volume] in Blood

11744

113916

1.19

7.44

32.8

14.7

4.42

4.59

e12/l

218.40

11486

110163

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

272

2.18

7.44

1.1

79.22

90.61

1.54

116

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

125

729

1.70

7.32

1.2

64.96

70.21

u/l

0.24

117

640

(3000963) Hemoglobin [Mass/volume] in Blood

11747

113968

1.19

7.31

33.1

14.8

133.21

138.00

g/l

209.75

11634

112154

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1739

19467

0.86

7.27

2.8

2.9

0.68

0.76

ug/l

1.78

1186

12184

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2447

26756

0.88

7.24

3.8

4.0

21.43

21.98

0.91

1030

12325

(3044941) Cell count panel - Synovial fluid

176

1122

1.56

7.21

1.4

1.3

—

(3049717) Cytology report of Urine Cyto stain

389

2877

1.35

7.17

2.4

2.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

342

2.03

7.17

1.4

1.2

166.43

172.95

mmol/24h

0.19

342

(3035320) C reactive protein [Mass/volume] in Body fluid

110

625

1.74

7.08

2.6

2.1

—

(3049233) Organic acids panel - Urine

6.87

6.91

1.4

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

101

2.94

6.88

1.0

0.02

0.38

u/ml

0.80

(3050129) First trimester maternal screen panel - Serum or Plasma

359

4708

0.75

6.88

1.5

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

134

2.66

6.88

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

529

1.80

6.87

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

530

1.79

6.83

1.3

1.1

—

(3034426) Prothrombin time (PT)

282

2.11

6.83

1.3

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

9559

91579

1.12

6.80

4.5

4.0

5.98

5.85

mmol/l

11.99

8775

84013

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

538

1.79

6.80

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

531

1.79

6.79

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

102

2.91

6.77

1.3

2.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

3.07

6.68

1.5

1.6

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

393

1.91

6.65

1.1

95.87

94.20

0.18

311

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

537

1.77

6.56

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

538

1.77

6.52

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

131

799

1.62

6.51

2.3

2.5

1.67

1.53

g/24h

0.19

396

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

138

2.58

6.51

1.7

2.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

106

612

1.72

6.49

1.3

2.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

446

1.84

6.47

1.6

1.32

1.22

nmol/l

0.35

354

(3003129) Base excess in Capillary blood by calculation

175

2.37

6.39

1.3

1.5

1.33

0.62

mmol/l

0.34

160

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

158

2.44

6.30

1.1

1.3

341.26

314.08

pmol/l

0.13

117

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

373

1.91

6.29

1.6

1.4

9.16

6.29

u/l

0.44

320

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.25

6.25

1.4

—

(3012565) Volume of 24 hour Urine

374

1.91

6.24

1.8

2.2

2120.70

2005.97

0.22

338

(3020961) Endomysium IgA Ab [Titer] in Serum

587

4672

1.25

6.24

1.1

80.38

274.08

titre

3.51

158

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

266

2.08

6.23

1.3

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

266

2.08

6.23

1.3

1.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

151

964

1.55

6.21

2.3

1.9

31.79

28.15

mg/l

0.28

245

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

173

2.34

6.08

2.2

3.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

205

2.22

6.02

1.8

3.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1043

8825

1.18

5.95

2.3

2.1

12.48

12.82

nmol/l

0.61

897

8027

(3016330) Potassium [Moles/time] in 24 hour Urine

116

2.64

5.90

1.2

—

78.28

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

273

2.03

5.84

1.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

106

2.70

5.78

5.6

5.3

53.28

43.51

ug/min

0.24

(3000330) Specific gravity of Urine by Test strip

507

4005

1.26

5.78

3.7

2.7

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.00

5.76

2.3

1.6

—

(3023383) Lactate [Moles/volume] in Pleural fluid

216

2.15

5.72

1.5

1.3

4.12

3.44

mmol/l

0.33

201

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

481

3781

1.27

5.72

1.3

227.31

228.41

miu/ml

0.02

183

1844

(3021788) Differential panel - Synovial fluid

198

1364

1.44

5.67

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

279

3679

0.74

5.62

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

279

3678

0.74

5.61

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

670

5477

1.22

5.58

1.1

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.87

5.57

1.3

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.65

5.52

1.8

1.7

58.65

39.48

umol/l

0.94

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

209

1462

1.42

5.51

1.1

10.14

9.89

au/ml

—

102

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

456

1.76

5.49

1.6

27.64

23.87

u/ml

0.30

108

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.72

5.47

1.0

1.5

4.37

224712.32

nmol/l

1.05

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

280

3674

0.75

5.47

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

111

681

1.61

5.46

1.6

1.5

31.49

31.73

0.02

419

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

306

3963

0.76

5.45

1.4

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

279

3658

0.75

5.42

1.4

—

(3032641) Amino acids panel - Urine

6.97

5.37

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

209

2.13

5.36

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

245

1771

1.37

5.34

1.7

1.6

13487.55

14146.56

e6/l

0.11

170

1300

(3022145) Colonoscopy Study observation

1091

9362

1.16

5.25

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

199

2.14

5.18

1.3

1.8

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

238

3170

0.74

5.16

1.7

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

287

2141

1.33

5.12

2.6

2.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

3.59

5.09

1.4

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

195

2.13

5.03

1.3

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

195

2.13

5.03

1.3

1.8

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1121

9677

1.16

4.99

2.2

2.0

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1465

0.63

4.79

2.8

2.2

13.17

13.08

0.36

1443

(3047352) Trisomy 18 risk [Likelihood] in Fetus

222

2944

0.74

4.72

1.4

—

(3005033) Fetal Nuchal fold Thickness US

222

2939

0.74

4.67

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

291

1.87

4.62

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

267

2004

1.32

4.61

1.4

—

(3003338) MCHC [Mass/volume]

9248

89012

1.09

4.59

29.4

12.6

333.87

333.71

g/l

0.85

9178

88215

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

114

2.43

4.56

1.0

—

(40768795) Lymph node Pathology biopsy report

483

1.66

4.53

1.2

1.1

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

230

3015

0.75

4.53

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

440

1.69

4.47

2.2

1.7

1.77

3.12

u/field

0.66

317

(3029075) Extractable nuclear Ab panel - Serum

199

2.04

4.42

1.0

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

3.01

4.40

1.3

0.97

1.20

ml/s/173m2

0.41

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

102

649

1.56

4.39

2.5

1.8

2.20

1.75

u/field

0.36

281

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

911

7823

1.16

4.38

2.0

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

3.23

4.36

1.2

1.1

13.56

14.73

u/l

0.05

(21494434) Karyotype in Bone marrow

527

1.62

4.34

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

658

5513

1.19

4.29

1.2

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

118

2.35

4.26

1.6

1.5

148.59

128.08

ng/l

0.21

118

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

3.05

4.25

1.1

1.3

—

(3002619) Bacteria identified in Specimen by Culture

169

2.11

4.25

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

9392

94804

0.92

4.24

4.3

3.9

1.41

1.43

mmol/l

3.39

8661

88404

(3045424) Erythrocytes [Presence] in Urine

189

1366

1.37

4.22

1.4

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1117

0.61

4.19

1.3

165.64

181.87

pmol/l

0.58

1117

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

657

1.54

4.18

1.2

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

262

3332

0.77

4.16

1.5

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

317

1.78

4.12

1.3

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

259

1970

1.30

4.11

4.2

3.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

3.10

4.10

1.3

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.53

4.09

2.4

2.6

14.39

7.28

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

271

2075

1.30

4.09

2.5

2.3

173.87

92.76

ug/min

1.73

153

1301

(3033086) Enterovirus NOS Ab [Titer] in Serum

5.17

4.09

1.0

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

146

2.17

4.06

2.2

2.5

6.21

8.16

mmol/l

1.70

(40768441) Liver Pathology biopsy report

568

1.57

4.05

1.7

1.3

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

121

2.29

4.04

1.6

1.5

37.38

176.21

ng/l

1.24

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

173

2.06

4.01

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

291

2257

1.28

3.99

1.9

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.15

3.96

1.4

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

205

1522

1.33

3.88

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

309

1.76

3.87

3.3

4.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.72

3.82

2.5

3.8

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

135

939

1.42

3.81

1.6

1.5

60.12

56.21

0.59

586

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

5.93

3.77

2.2

1.6

252.78

284.20

nmol/l

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.64

3.74

1.6

1.0

—

(3013931) Oligosaccharides [Presence] in Urine

11.85

3.73

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

193

1.95

3.67

1.3

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

435

1.61

3.65

2.0

116.28

100.94

ug/min

0.12

102

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1140

12541

0.89

3.62

1.5

1.4

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.35

3.57

1.5

1.4

452.79

681.26

nmol/l

0.59

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.82

3.53

1.1

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

211

1.87

3.48

1.7

2.1

197.50

112.84

ng/l

0.53

136

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

334

2683

1.23

3.44

1.1

3.99

7.28

u/ml

0.98

383

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

118

818

1.43

3.44

1.2

1.1

—

(40768443) Skin Pathology biopsy report

436

3598

1.20

3.44

1.2

—

(3017704) Immunofixation for Urine

308

1.70

3.36

1.2

1.5

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.47

3.34

1.1

1.3

0.45

0.59

umol/24h

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

167

1233

1.34

3.34

1.3

30.36

27.54

u/l

0.18

142

1053

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

4.02

3.34

6.8

6.1

575.45

508.59

umol/l

0.35

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

6.91

3.33

1.6

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.94

3.33

1.4

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

187

1.90

3.29

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.88

3.24

1.5

5.5

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

3.88

3.24

6.6

5.9

19.28

17.22

mmol/l

0.61

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

442

1.57

3.22

1.4

2.0

4.11

3.55

mg/l

0.51

423

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

665

1.46

3.22

1.4

1.2

4.42

5.63

umol/l

2.98

619

(3033923) Metanephrine [Moles/time] in 24 hour Urine

128

2.08

3.18

1.0

1.1

0.71

1.19

umol/24h

0.49

(3004616) Nuclear Ab [Presence] in Serum

121

856

1.40

3.18

1.3

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

329

1.65

3.16

1.0

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

546

0.52

3.14

1.2

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.49

3.14

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1521

13780

1.10

3.09

1.8

1.7

—

(44786800) Granulocytes/100 leukocytes in Body fluid

2.38

3.04

1.6

1.3

24.94

26.79

0.09

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

7.41

3.02

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

684

1.43

2.99

1.3

181865.32

124298.43

e6/l

0.27

459

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

435

1.55

2.99

1.6

1.5

9.86

6.87

u/l

0.53

354

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

219

2718

0.79

2.97

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

107

752

1.41

2.95

3.5

3.1

133.05

60.31

mg/l

0.67

549

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

3215

33407

0.93

2.89

4.3

4.6

2.52

2.70

ug/l

0.33

2821

30127

(3004347) Hepatitis D virus Ab [Presence] in Serum

4.04

2.84

1.1

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

6.58

2.84

1.0

1.1

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

5.32

2.83

2.0

1.5

486.57

401.40

nmol/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

108

767

1.39

2.82

3.5

4.8

162.41

89.09

u/ml

0.39

252

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.40

2.79

1.1

28.45

19.07

u/l

0.94

(42529582) MDA5 Ab [Presence] in Serum by Line blot

149

1.92

2.78

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

149

1.92

2.78

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

149

1.92

2.78

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

149

1.92

2.78

1.0

1.1

—

(3020491) Glucose [Moles/volume] in Blood

686

1.41

2.78

1.8

1.7

6.92

6.50

mmol/l

0.55

495

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

596

1.44

2.78

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

9511

95491

0.94

2.72

4.3

3.9

4.50

4.66

mmol/l

42.20

8801

89468

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

219

1.72

2.56

1.8

1.5

0.17

nmol/l

0.04

154

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

197

1552

1.26

2.52

1.6

1.5

0.28

0.45

nmol/l

4.34

155

1265

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

9095

91367

0.94

2.51

3.9

3.5

1.34

1.28

mmol/l

6.34

8346

84643

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

134

1.92

2.50

1.4

1.5

0.31

0.43

ug/l

1.12

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.94

2.44

1.0

1.1

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

4.32

2.44

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

4.32

2.44

1.0

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

530

1.44

2.44

1.2

52.50

54.53

u/ml

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

211

1683

1.24

2.44

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

108

2.01

2.42

1.6

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.09

2.39

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.09

2.39

1.0

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

533

1.43

2.38

1.2

81.00

34.75

u/ml

—

(3050794) Legionella sp Ab [Presence] in Serum

2.52

2.37

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

972

0.70

2.33

1.4

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

335

3878

0.85

2.31

1.7

1.5

3.81

3.79

mg/l

0.01

263

2641

(3024263) Appearance of Synovial fluid

407

1.48

2.29

1.5

1.4

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

400

1.48

2.26

1.1

1.2

152.69

19.03

u/ml

0.44

264

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

4.56

2.24

1.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

4.56

2.24

7.3

1.0

93.22

138.81

mg/l

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

323

0.49

2.24

1.3

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

105

1.98

2.22

1.3

0.34

1.39

mmol/l

1.09

(40762887) Creatinine [Moles/volume] in Blood

5.49

2.19

1.4

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

5.49

2.19

3.8

3.3

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

379

1.49

2.19

1.1

232.18

199.44

iu/ml

0.21

379

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.65

2.16

1.0

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

208

1.66

2.16

1.3

51.58

54.34

0.15

177

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.02

2.14

4.3

2.2

0.37

0.54

u/field

0.61

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

537

1.40

2.13

1.3

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

4.23

2.12

7.0

1.1

—

(4034850) Laboratory test

330

2790

1.17

2.11

11.9

8.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

431

1.45

2.11

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

2.00

2.08

1.3

1.4

5.31

10.04

1.04

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

692

0.67

2.05

1.2

1.3

1.52

1.53

g/l

0.11

692

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

9672

96809

0.95

2.04

4.7

4.3

2.64

2.79

mmol/l

54.17

8911

90136

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.87

2.03

1.2

1.4

—

(3036048) Francisella tularensis Ab [Titer] in Serum

145

1.77

2.01

1.1

1.2

—

470.00

—

(3020618) Glucose [Moles/volume] in Synovial fluid

3.95

2.01

1.0

5.05

5.38

mmol/l

—

(3000285) Sodium [Moles/volume] in Blood

2.05

2.00

1.1

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.04

1.98

1.4

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

372

1.46

1.97

1.1

1.3

—

(40768800) Prostate Pathology biopsy report

165

2005

0.81

1.97

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

504

1.39

1.96

1.2

2.80

11.22

u/ml

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

214

1.62

1.96

1.6

1.5

11.51

8.85

ug/l

1.23

214

(40765096) Chromosome analysis panel by Banding

133

1.78

1.91

1.4

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

133

1.78

1.91

1.4

1.2

1.34

1.77

mmol/l

1.34

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.70

1.91

1.2

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.53

1.90

1.1

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

2.32

1.89

1.8

1.4

19.45

20.40

pmol/l

0.05

(4094501) Cardiovascular stress test using bicycle ergometer

193

2293

0.83

1.86

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.14

1.85

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

595

1.35

1.84

1.3

1.41

3.83

u/ml

2.33

333

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.53

1.83

1.3

1.2

—

(3002256) Pathology report gross observation

1210

11127

1.08

1.83

1.3

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

433

0.61

1.78

4.7

6.5

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.01

1.77

1.9

1.4

—

(3036670) Protein [Mass/volume] in Synovial fluid

213

1.58

1.76

1.3

1.2

38.63

40.59

g/l

0.23

115

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

175

1.64

1.74

1.3

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

175

1.64

1.74

1.3

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

138

1.72

1.71

1.3

0.48

48.28

mg/l

0.71

103

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

131

1.73

1.70

1.0

1.1

0.21

4.17

u/ml

0.80

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.91

1.68

1.5

1.3

32.67

452.58

u/l

0.70

(3045683) HLA typing for celiac disease panel - Blood or Tissue

596

1.33

1.68

1.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

117

1444

0.80

1.67

1.1

1.01

0.38

u/ml

0.41

419

(3034274) Bile acid [Moles/volume] in Serum --fasting

186

1538

1.20

1.62

2.4

2.3

9.36

6.38

umol/l

0.87

141

1132

(40761995) Spermatozoa Progressive [#/volume] in Semen

433

0.64

1.61

2.3

3.3

—

(3006270) Folate [Moles/volume] in Blood

680

1.29

1.58

1.1

352.35

371.35

nmol/l

0.37

595

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.66

1.55

1.0

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

536

1.33

1.55

1.3

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

290

2499

1.15

1.54

2.0

1.8

197.46

199.28

pmol/l

0.09

279

2379

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.88

1.54

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.17

1.52

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

453

1.35

1.51

7.6

6.4

4054.13

7287.27

u/ml

0.19

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

175

1.58

1.50

1.3

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1048

11059

0.93

1.49

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

339

0.61

1.47

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

482

0.68

1.47

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

154

1819

0.83

1.46

1.1

5.62

4.96

u/ml

0.15

965

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.81

1.45

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

185

1548

1.18

1.45

1.2

—

(3013862) HLA-DP [Type]

3.09

1.42

1.0

—

(46236302) HLA-C [Type] by High resolution typing

3.09

1.42

1.0

—

(40760409) HLA-A [Type] by High resolution

3.09

1.42

1.0

—

(40763590) HLA-DQ beta [Type]

3.09

1.42

1.0

—

(40760410) HLA-B [Type] by High resolution

3.09

1.42

1.0

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

120

968

1.23

1.39

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

102

1.74

1.39

1.8

2.0

2.78

5.10

nmol/l

0.49

(4212803) Bone marrow aspirate examination

2.01

1.38

1.1

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.95

1.38

1.0

1.2

1.85

1.89

umol/24h

0.04

(3021706) Oxygen [Partial pressure] in Arterial cord blood

179

1.55

1.38

1.0

3.19

3.49

kpa

0.52

152

(3034891) Synovial lining cells/100 cells in Synovial fluid

359

1.38

1.7

1.4

5.25

3.16

0.36

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

180

1.54

1.35

1.1

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

123

1470

0.82

1.35

1.3

1.4

7.25

7.03

mmol/l

0.30

114

1307

(3016750) Collection duration of Urine

497

1.31

1.35

2.5

2.2

500.52

495.72

min

0.14

388

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

1.34

0.0

1.0

—

(3019174) dRVVT (LA screen)

1.87

1.34

1.1

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

143

1683

0.84

1.34

1.1

8.23

6.20

u/ml

0.23

773

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

246

2768

0.87

1.30

1.5

1.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

288

1.41

1.30

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

115

932

1.22

1.29

1.4

8.77

8.02

mmol/l

1.06

110

897

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

135

1.61

1.29

1.0

1.1

0.10

0.48

u/ml

1.08

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

322

1.38

1.28

1.7

2.0

—

(3008898) HLA-B27 [Presence]

368

3270

1.11

1.25

1.1

—

(3007916) DNA double strand Ab [Titer] in Serum

1.82

1.25

1.4

—

291.70

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

184

1.50

1.24

1.0

7.20

7.32

kpa

0.12

158

(3006598) pH of Arterial cord blood

184

1.50

1.24

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

184

1.50

1.24

1.0

-2.14

-2.02

mmol/l

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

2.02

1.24

6.1

3.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.74

1.23

1.1

24.93

12.26

u/ml

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

225

1.45

1.23

9.3

6.8

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.91

1.23

2.2

2.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.98

1.23

1.4

317.09

325.18

umol/24h

0.04

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

122

1.62

1.21

1.0

1.1

0.36

0.39

u/ml

0.03

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

218

1.45

1.20

1.2

1.1

20.10

20.01

mmol/l

0.05

201

(3035933) Granulocytes/100 leukocytes in Blood

301

1.38

1.20

1.5

1.4

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

194

1.48

1.19

1.3

34.05

40.21

0.41

123

(3014891) Appearance of Pleural fluid

1.83

1.19

1.3

1.2

—

(3004775) Volume in Urine collected for unspecified duration

683

1.24

1.19

2.4

2.3

720.50

634.14

1.14

482

(3022689) Creatine [Moles/volume] in Urine

260

1.41

1.19

2.0

1.4

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

697

0.76

1.19

1.2

1.4

29.45

31.65

nmol/l

0.23

649

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.08

1.16

1.9

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

783

0.78

1.16

1.6

1.4

—

(44813793) Dust mix specific IgE antibody measurement

704

1.24

1.15

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.72

1.14

1.0

172.73

163.60

g/l

1.18

(3001729) Color of Synovial fluid

1.91

1.13

1.5

1.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

388

3482

1.10

1.12

2.8

2.9

119.09

47.98

u/ml

0.45

378

3357

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

141

1.54

1.11

3.9

7.2

63.56

72.33

0.66

115

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

102

1.65

1.11

1.4

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

157

1332

1.17

1.11

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

156

1326

1.16

1.08

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

195

1685

1.14

1.08

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.94

1.07

1.2

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.35

1.07

1.0

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

119

1.58

1.06

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

523

0.75

1.00

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

304

1.33

0.99

1.4

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

130

0.53

0.98

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

163

1837

0.87

0.96

1.2

—

(4146454) Self-monitoring of blood glucose

105

877

1.18

0.93

3.1

2.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.74

0.93

12.9

8.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

198

2197

0.89

0.92

1.1

3.20

2.82

u/ml

0.15

114

1223

(3020650) Glucose [Presence] in Urine

260

0.68

0.85

1.2

1.4

—

(3025130) Human papilloma virus identified in Specimen

139

1206

1.14

0.79

1.8

1.7

—

(3000492) Spirometry study

1036

9783

1.05

0.79

1.5

1.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.67

0.79

1.1

1.2

—

(4281824) Cell count and differential, peritoneal fluid

729

1.18

0.78

1.2

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

171

1.39

0.78

1.0

1.1

5.57

4.06

u/ml

0.17

138

(3015076) Soybean IgE Ab [Units/volume] in Serum

685

0.82

0.77

1.2

1.1

1.55

0.77

u/ml

0.61

233

(3051101) Glucose [Moles/volume] in Cord blood

159

0.62

0.75

4.3

6.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.60

0.74

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.54

0.74

1.1

—

(3047189) Immunofixation for 24 hour Urine

285

1.28

0.74

1.4

1.9

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.62

0.72

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

200

1.33

0.71

9.9

6.9

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

244

1.30

0.69

1.4

1.2

—

(3022670) pH of Venous cord blood

1.53

0.68

1.0

—

(3006462) Nitrate [Presence] in Urine

425

1.21

0.65

2.8

2.9

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

152

1.36

0.64

1.1

1.2

—

(3025577) Chromium [Mass/volume] in Blood

463

0.81

0.62

1.9

2.0

1.68

2.26

ug/l

1.12

384

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.60

0.0

1.0

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.60

0.0

2.1

—

7.26

—

(3027035) Albumin [Mass/time] in 24 hour Urine

1.50

0.59

1.4

1.2

—

380.23

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

149

0.66

0.59

1.1

1.9

2.30

2.26

ug/l

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.59

0.0

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.74

0.58

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.46

0.56

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

114

1.39

0.55

1.1

1.0

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

1421

0.90

0.55

1.1

2.42

4.11

u/ml

1.67

713

(3005011) Chlamydia sp Ab [Titer] in Serum

140

1.34

0.54

1.2

1.5

—

(40758292) HTLV I+II Ab panel - Serum

141

1.33

0.52

1.3

1.4

—

(3013762) Body weight Measured

1.52

0.52

1.3

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

557

1.15

0.51

1.1

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1106

10584

1.03

0.51

4.2

4.1

32.50

31.99

0.75

828

7332

(3013466) aPTT in Blood by Coagulation assay

1.54

0.48

1.1

40.00

38.49

—

(40768793) Breast Pathology biopsy report

137

1479

0.91

0.48

1.4

1.3

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

563

1.14

0.45

1.4

1.3

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

198

1.25

0.45

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

172

1.26

0.44

1.0

1.1

4.92

8.61

u/ml

0.32

140

(3025018) Bordetella pertussis Ab [Titer] in Serum

575

1.13

0.43

1.2

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

120

1.32

0.43

1.2

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.41

0.0

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.0

—

9.12

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.32

0.39

1.0

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

105

1.32

0.38

1.1

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

115

1.29

0.36

1.2

1.3

55.58

43.12

mg/l

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

245

2549

0.95

0.35

1.2

1.1

2.71

2.65

u/ml

0.03

143

1383

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.41

0.35

1.7

2.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

124

0.72

0.35

11.1

5.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.38

0.34

1.0

1.1

—

(3048879) Bone marrow aspiration report

161

1.23

0.33

1.3

2.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1402

14115

0.98

0.33

1.5

—

(1002224) Polysomnography panel

409

4194

0.96

0.33

1.1

—

(3001556) Androgen free Index in Serum or Plasma

135

1.24

0.32

1.4

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

300

1.15

0.31

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

145

1.23

0.30

8.4

6.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

301

1.15

0.30

1.3

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

182

1.19

0.29

1.5

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

172

1793

0.95

0.29

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

172

1793

0.95

0.29

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

213

2205

0.95

0.28

1.1

1.11

1.29

u/ml

0.21

103

1097

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

351

1.13

0.27

2.4

2.1

8.06

9.92

mg/l

1.39

291

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.23

0.27

1.4

1.3

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

369

0.88

0.26

1.0

13.65

14.94

u/ml

0.11

219

(3003888) Timothy IgE Ab [Units/volume] in Serum

223

2299

0.96

0.26

1.1

7.47

7.09

u/ml

0.11

123

1342

(3010937) Rubella virus Ab [Presence] in Serum

1.22

0.25

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.17

0.24

1.0

1.1

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

289

1.13

0.24

1.1

1.2

2.98

12.64

u/ml

1.63

220

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.23

0.22

1.8

4.1

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

301

1.12

0.21

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.21

0.0

1.4

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3012138) Guinea pig epithelium IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.93

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

227

0.87

0.20

1.0

1.1

40.49

56.76

u/ml

0.77

222

(3022475) Manganese [Moles/volume] in Blood

1.23

0.20

1.0

1.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

121

0.82

0.19

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

107

1.20

0.19

1.0

1.52

1.29

u/ml

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

686

1.07

0.19

1.0

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

757

0.94

0.19

1.2

1.1

10.51

6.37

u/ml

0.17

253

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.14

0.19

1.3

1.2

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

1.21

0.18

1.0

0.21

0.43

u/ml

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

623

1.06

0.16

1.0

1.1

20.00

8.13

iu/ml

1.34

152

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

191

0.88

0.16

1.5

1.2

—

(3020874) Milk IgE Ab [Units/volume] in Serum

779

0.95

0.14

1.2

8.81

3.80

u/ml

0.36

314

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

127

0.85

0.14

1.0

—

(40762814) Titanium [Mass/volume] in Blood

116

0.85

0.13

2.2

2.4

7.54

3.13

ug/l

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

388

3760

1.02

0.13

1.9

1.7

44.55

40.32

nmol/l

1.86

379

3672

(3051387) C reactive protein [Mass/volume] in Capillary blood

211

2031

1.03

0.12

3.6

2.9

26.70

27.93

mg/l

0.19

124

1292

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

294

2843

1.02

0.12

1.4

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

421

4226

0.98

0.12

1.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

114

0.87

0.11

1.5

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

425

0.95

0.08

1.0

1.1

22.80

10.36

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.80

0.07

1.2

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

126

1.10

0.07

1.3

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

170

1705

0.98

0.06

1.3

3.27

4.02

ug/l

1.62

156

1590

(3008607) Semen analysis panel

119

0.91

0.05

1.2

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

418

0.97

0.04

2.6

3.3

93.09

124.32

au/ml

0.33

(40765089) Chromosome analysis panel - Blood by G-banded

519

1.03

0.04

1.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

452

1.03

0.03

3.1

4.1

8.36

8.18

mg/l

0.09

368

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

127

0.93

0.03

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

473

0.98

0.02

6.1

7.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

661

0.99

0.02

2.3

1.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

144

0.96

0.00

1.5

1.2

7.18

7.68

mmol/l

—

(3029396) Erythrocyte agglutination [Presence] in Blood

350

1.02

0.00

2.6

2.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

101

0.98

0.00

4.5

3.4

—

(3009871) Measles virus Ab [Titer] in Serum

294

1.01

0.00

1.9

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

104

0.95

0.00

1.3

3.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.0

2.0

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.88

-0.00

9.0

6.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

-0.00

0.0

1.0

—

16.00

—

(3014178) Parietal cell Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: R18_CONVU_NOT_ELSEW_CLASSIFIED – Convulsions, not elsewhere classified

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Convulsions, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Convulsions, not elsewhere classified (R18_CONVU_NOT_ELSEW_CLASSIFIED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints